Dr. Zaloga's publications

Scientific Meetings:

  1. Zaloga G, Sarma R. New Method for Extending the Diffraction Pattern from Protein Crystals and Preventing their Radiation Damage. The Second East Coast Protein Crystallographic Workshop, 1974.
  2. Laudin A, Sarma R, Zaloga G. Structure Analysis of an Intact Immunoglobulin - New Method of Preventing Radiation Damage and Extension of Diffraction Data. World Crystallographic Convention, 1975.
  3. Zaloga G, Chin R, Spurling T, Richter J. Gastrointestinal Manifestations of Arsenic Intoxication - A Case Report and Review of the Literature. Air Force Regional Meeting of the American College of Physicians. Sacramento, CA, March 1982.
  4. Zaloga G, Chernow B, Rainey T, Hughes P, Lake CR. Vasodilator therapy in pulmonary hypertension. Air Force Regional Meeting of the American College of Physicians. Sacramento, CA, March 1982.
  5. Spurling T, Zaloga G, Richter J. Endoscopic Removal of Gastric Foreign Body with Overtube Technique. Air Force Regional Meeting of the American College of Physicians. Sacramento, CA, March 1982.
  6. Finton C, Chernow B, Bjorkland S, Zaloga G. Gentamicin Induced Hypomagnesemia. Air Force Regional Meeting of the American College of Physicians. Sacramento, CA, March 1982.
  7. Finton C, Chernow B, Bjorkland S, Zaloga G. Gentamicin Induced Hypomagnesemia. Society of Critical Care Medicine Annual Scientific and Educational Symposium. St. Louis, MS, June 1982.
  8. Chernow B, Zaloga GP, Lake CR, Rainey TG, Casey L, Fletcher JR. The Endogenous Catecholamine Response to Critical Illness - Implications for Therapy. Regional Meeting of the American College of Physicians. Baltimore, MD, October 1982.
  9. Chernow B, Zaloga GP, Pock A, Zaritsky A, Wood B. Aminoglycoside Induced Hypomagnesemia - A Prospective Study. Joint Meeting of the Southern Section of the American Federation for Clinical Research, the Southern Society for Clinical Investigation, and the Southern Society for Pediatric Research. New Orleans, LA, January 1983.
  10. Chernow B, Zaloga GP. Reagent Strip Testing in Critical Care Medicine -The Bedside Laboratory. Laboratory Testing: New and Future Procedures, An International Symposium to Evaluate the New Methods in Urinalysis and Developments in Dry Chemistry. Tarpan Springs, FL, February 1983.
  11. Zaloga GP, Chernow B, Hughes P, Fletcher JR, Rainey T, Lake CR. Human Pulmonary Hypertension -Correlation with Mixed Venous Catecholamines. Air Force Regional Meeting of The American College of Physicians. San Antonio, TX, March 1983.
  12. Chernow B, Zaloga G, Quinn T, Burman K, Zajtchuk R. Altered Thyroid Function Following Cardiopulmonary Bypass Surgery - A Longitudinal Study. Air Force Regional Meeting of the American College of Physicians. San Antonio, TX, March 1983.
  13. Zaloga GP, Chernow B, Pock A, Wood B, Zaritsky A, Zucker A. Aminoglycoside Induced Hypomagnesemia - A Prospective Study. Air Force Regional Meeting of the American College of Physicians. San Antonio, TX, March 1983.
  14. Chernow B, Zaloga G, Burman K, Zajtchuk R, Rainey T, Lake CR. Hemodynamic and Catecholamine Response to TRH in Patients Undergoing Cardiac Surgery. Air Force Regional Meeting of the American College of Physicians. San Antonio, TX, March 1983.
  15. Chernow B, Zaloga GP, Burman KD, Chin R, Zajtchuk, R, Rainey TG, Lake CR. Diagnostic Dosages of TRH Raise Blood Pressure by a Noncatecholamine Mechanism. Society of Critical Care Medicine Twelfth Annual Educational and Scientific Symposium. New Orleans, LA, May 1983.
  16. Chernow B, Zaloga GP, Burman K, Quinn T, Rainey TG, Zajtchuk R. Cardiopulmonary Bypass Surgery Rapidly Alters Thyroid Function. Society of Critical Care Medicine Twelfth Annual Educational and Scientific Symposium. New Orleans, LA, May 1983.
  17. Barber WB, Smith LE, Zaloga G, Cook D, Fletcher JR, Lake CR, Chernow B. The Hemodynamic and Plasma Catecholamine Response to Perianal Local Anesthesia. American Society of Colon and Rectal Surgeons. Boston, MA, June 1983.
  18. Engler RJM, Gurney M, Zaloga G, Eil C. Menstrual Urticaria-Angioedema Secondary to Autoimmune IgE to FSH/LH. Eastern Section of the American Federation for Clinical Research, Cambridge, MA, October 1983.
  19. Zaloga GP, Eil C, O'Brian JT. Hypocalciuric Hypercalcemia in a Patient with Hypothyroidism. Air Force Regional Meeting of the American College of Physicians. Colorado Springs, CO, March 1984.
  20. Zaloga GP, Chernow B, Eil C. The Enterohepatic Circulation for Vitamin D - A Cause of Hypocalcemia in a Patient with Inflammatory Bowel Disease. Air Force Regional Meeting of the American College of Physicians. Colorado Springs, CO, March 1984.
  21. Zaloga GP, Chernow B, Cook D, et al. The Importance of Measured Ionized Calcium Levels in Critically Ill Patients. Society of Critical Care Medicine Annual Educational and Scientific Symposium. San Francisco, CA, May 1984.
  22. Zaloga GP, Chernow B, Zajtchuk R, et al. Critical Illness Decreases Thyrotropin Responsiveness to Thyrotropin Releasing Hormone - A Potential Cause of Misinterpretation of Thyroid Function Tests in Critically Ill Patients. Society of Critical Care Medicine Annual Educational and Scientific Symposium. San Francisco, CA, May 1984.
  23. Kurek T, Zaloga GP, Chernow B, et al. Total Serum T4 Concentrations Correlate with Severity of Illness (APACHE SCORE) in Critically Ill Euthyroid Patients. National Meeting of the American Federation for Clinical Research, Washington, DC, May 1984.
  24. Chernow B, Smallridge R, Snyder R, Zaloga G, Burman K. Angiotensin Converting Enzyme Activity in Acute Illness. Annual Meeting and Scientific Session of the Uniformed Services Section, Society of Critical Care Medicine, San Francisco, CA, May 1984.
  25. Zaloga GP, Clapper M, Chernow B. Variability in the Percentage of Protein Binding of Calcium may Explain the Poor Correlation Between Serum Total and Ionized Calcium Measurements in Critically Ill Patients. Eastern Section of the American Federation for Clinical Research, Philadelphia, PA, October 1984.
  26. Engler RJM, Zaloga GP. Anaphylaxis to Tetanus Toxoid - IgE Mediated Disease. American Academy of Allergy and Immunology. February 1985.
  27. Zaloga GP, Malcolm D, Holaday J, Chernow B. Glucagon is a Unique Cardiovascular Agent with Anti-opiate Activity. Society of Critical Care Medicine Annual Educational and Scientific Symposium, Chicago, IL, May 1985.
  28. Zaloga GP, Malcolm D, Holaday J, Chernow B. Glucagon Reverses the Hypotension and Bradycardia of Verapamil Overdose in Rats. Society of Critical Care Medicine Annual Educational and Scientific Symposium, Chicago, IL, May 1985.
  29. Zaloga GP, Malcolm D, Holaday J, Chernow B. Effective Treatment of Acute Calcium Cardiotoxicity with Verapamil in Rats. Society of Critical Care Medicine Annual Educational and Scientific Symposium, Chicago, IL, May 1985.
  30. Malcolm D, Zaloga GP, Chernow B, Holaday J. Glucagon Antagonizes Opioid Induced Bradycardia and Analgesia. Fifth International Washington Symposium on Neural and Endocrine Peptides and Receptors, Washington, DC, May 1985.
  31. Zaloga GP, Chernow B. Free Fatty Acids Increase Calcium Binding to Albumin in Serum From Critically Ill Patients. National Meeting of the American Federation for Clinical Research, Washington, DC, May 1985.
  32. Zaloga GP, Malcolm D, Chernow B, Holaday J. Glucagon Antagonizes Morphine Induced Bradycardia at a Site Within the Central Nervous System. National Meeting of the American Federation for Clinical Research, Washington, DC, May 1985.
  33. Teich S, Malcolm D, Zaloga G, Holaday J, Chernow B. Beneficial Effects of Glucagon in Endotoxic Shock in Rats. Eighth Annual Conference on Shock, Baltimore, MD, June 1985.
  34. Malcolm DS, Zaloga GP, Teich S, Chernow B, Holaday JW. Central Glucagon Antagonizes Morphine Antinociception in the Rat. International Research Conference (INRC 85), North Falmouth, MA, June 1985.
  35. Zaloga GP, Chernow B. Pathogenic mechanisms for hypocalcemia during gram negative sepsis. Society of Critical Care Medicine Annual Scientific and Educational Symposium, Washington, DC, May 1986.
  36. Zaloga GP, Willey S, Chernow B. Altered calcium binding in severe illness: A common cause for misinterpretation of serum calcium values in critically ill patients. Society of Critical Care Medicine Annual Scientific and Educational Symposium, Washington, DC, May 1986.
  37. Willey S, Zaloga GP, Malcolm D, Chernow B, Holaday J. Calcium inhibits epinephrine's vasopressor effect in normal and endotoxic rats. Society of Critical Care Medicine Annual Scientific and Educational Symposium, Uniformed Services Subsection, Washington, DC, May 1986.
  38. Malcolm D, Zaloga GP, Chernow B, Holaday J. Calcium involvement in endotoxic shock: Verapamil improves hemodynamics and survival in rats. 9th Annual Conference on Shock, Scottsdale, AZ, June 1986.
  39. Quirk R, Masson E, Lake CR, Chernow B, Zaloga GP, Labow J. Neurochemical effects of phenylpropanolamine. American society for pharmacology and experimental therapeutics, Baltimore, MD, 1986.
  40. Willey S, Zaloga GP, Malcolm D, Chernow B, Holaday J. Calcium inhibits epinephrine's hypertensive effects in normal and endotoxic rats. American Federation for Clinical Research - Eastern Section, New York, NY, October 1986.
  41. Zaloga GP, Malcolm D, Willey SC, Amir S, Chernow B, Holaday J. Naloxone potentiates epinephrine's hypertensive effects in endotoxic rats. American Federation for Clinical Research - Eastern Section, New York, NY, October 1986.
  42. Wilkins RC, Tourville J, Klym DM, Zaloga GP. A simple method for determining physiologically active calcium and magnesium concentrations in critically ill patients. 21st Annual ASHP Midyear Clinical Meeting, Las Vegas, NV, December 1986.
  43. Reed HL, Chernow B, Lake CR, Zaloga GP, et al. Sympathetic nervous system "switch off" with profound intraoperative hypothermia during coronary artery bypass surgery. Air Force Regional Meeting of the American College of Physicians, New Orleans, LA, 1987.
  44. Zaloga GP, Malcolm D, Holaday J. Endotoxin-induced hypocalcemia results in defective calcium mobilization in rats. 16th Annual Scientific and Educational Symposium, Society of Critical Care Medicine, Anaheim, CA, May 1987.
  45. English JF, Coyle JP, Rainey TG, Wilkins L, Carrio J, McCormick C, Zaloga GP. Bedside laboratory testing accurately reflects main hospital laboratory results in critically ill patients. 16th Annual Scientific and Educational Symposium, Society of Critical Care Medicine, Anaheim, CA, May 1987.
  46. Zaloga GP, Malcolm D, Willey S, Holaday J. Hypocalcemia potentiates epinephrine-stimulated hepatic gluconeogenesis in normal and endotoxemic rats. 16th Annual Scientific and Educational Symposium, Society of Critical Care Medicine, Anaheim, CA, May 1987.
  47. Zaloga GP. Calcium Homeostasis During Critical Illness. International Symposium on Role of Divalent Metals in Critical Care Medicine, Honolulu, HI, June 1987.
  48. Zaloga GP. In-vivo and ex-vivo monitoring of the critically ill patient. American Association for Clinical Chemistry 39th National Meeting, San Francisco, CA, July 1987.
  49. Mark L, Strickland R, Butterworth J, Zaloga G. Calcium blunts epinephrine's inotropic effect in post-operative heart surgery patients. Society for Cardiovascular Anesthesiologists, New Orleans, LA, April 1988.
  50. Lake CR, Bray J, Rosenberg D, Moore S, Masson E, Zaloga G. Phenylpropanolamine (PPA) causes hypertension. 12th Scientific Meeting of the International Society of Hypertension, Kyoto, Japan, May 1988.
  51. Zaloga GP, Washburn D. Multi-organ failure is associated with elevated free intracellular calcium in human sepsis. American College of Chest Physicians, Anaheim, CA, October 1988.
  52. Zaloga GP. Bedside placement of feeding tubes into the duodenum in critically ill patients. American College of Chest Physicians, Anaheim, CA, October 1988.
  53. Strickland RA, Hill TR, Zaloga GP. Rapid bedside analysis of arterial blood gases and electrolytes improves patient care during and after cardiac surgery. American Society of Anesthesiologists, San Francisco, CA, October 1988.
  54. Strickland RA, Mark LJ, Butterworth JF, Zaloga GP. Calcium administration attenuates the hypertensive response to phenylephrine in humans following open heart surgery. American Society of Anesthesiologists, San Francisco, CA, October 1988.
  55. Zaloga GP, Hughes SS. Urine sodium excretion separates hypovolemic from normovolemic (hormonal excess) oliguria. American Society of Anesthesiologists, San Francisco, CA, October 1988.
  56. Strickland RA, Mark LJ, Butterworth JF, Zaloga GP. Intravenous calcium fails to augment cardiac output following cardiac surgery. American Society of Anesthesiologists, San Francisco, CA, October 1988.
  57. Prielipp RC, Washburn D, Zaloga GP. Albumin: an endogenous calcium antagonist? American Society of Anesthesiologists, San Francisco, CA, October 1988.
  58. Mark LJ, Strickland RA, Butterworth JF, Washburn D, Mills SA, Kon ND, Zaloga GP. Calcium blunts epinephrine's cardiac, peripheral vascular, and hyperglycemic effects in post-operative heart surgery patients. International Anesthesia Research Society, Orlando, FL, March 1989.
  59. Prielipp RC, Vilims BD, Zaloga GP. Acute changes in extracellular pH augment epinephrine-induced cAMP production in rat myocardial cells. Annual Meeting of the Society of Cardiovascular Anesthesiologists, Seattle, WA, April 1989.
  60. Robertie PG, Butterworth JF, Zaloga GP, Royster RL. Transient hypoparathyroidism during cardiopulmonary bypass. Annual Meeting of the Society of Cardiovascular Anesthesiologists, Seattle, WA, April 1989.
  61. Zaloga GP, Prielipp R, Hill T. Calcium causes catecholamine resistance by altering cyclic AMP production. Society of Critical Care Medicine, New Orleans, LA, June 1989.
  62. Zaloga GP, Vilims B, Prielipp R. Acute acidosis and alkalosis augments the cyclic AMP response to epinephrine in isolated myocardial cells. Society of Critical Care Medicine, New Orleans, LA, June 1989.
  63. Meredith JW, Ditesheim JA, Zaloga GP. Visceral protein synthesis is greater with peptide-diet versus intact-protein diet in trauma patients. Annual Meeting of the American Association for the Surgery of Trauma, Chicago, IL, October 1989.
  64. Prielipp RC, Ward KA, Zaloga GP. Peptide-based enteral nutrition prevents liver injury during hemorrhagic shock in rats. American Society of Anesthesiologists, New Orleans, LA, October 1989.
  65. Vilims BD, Prielipp RC, Ward KA, Zaloga GP. Acidosis and alkalosis fail to suppress epinephrine-induced cAMP production in rat myocardial cells. American Society of Anesthesiologists, New Orleans, LA, October 1989.
  66. Prielipp RC, Ward KA, Zaloga GP. An endogenous lipid, lysophosphatidyl choline, increases free cytosolic calcium levels in isolated rat myocardial cells. American Society of Anesthesiologists, New Orleans, LA, October 1989.
  67. Prielipp RC, Ward KA, Zaloga GP. Magnesium inhibits the calcium ionophoric properties of lysophosphatidyl choline, an endogenous arrhythmogenic substance. American Society of Anesthesiologists, New Orleans, LA, October 1989.
  68. Prielipp RC, Ward KA, Zaloga GP. Increased cytosolic calcium inhibits cAMP response to epinephrine in isolated rat myocardial cells. American Society of Anesthesiologists, New Orleans, LA, October 1989.
  69. Robertie PG, Butterworth JF, Royster RL, Tucker WY, Zaloga GP. Transient hypoparathyroidism during CPB: Calcium, magnesium, PTH, and vitamin D homeostasis. American Society of Anesthesiologists, New Orleans, LA, October 1989.
  70. Royster RL, Robertie PG, Butterworth JF, Kon ND, Zaloga GP. A randomized, blinded evaluation of calcium chloride, epinephrine and placebo for emergence from CPB. American Society of Anesthesiologists, New Orleans, LA, October 1989.
  71. Zaloga GP, Prielipp R, Ward K. Intracellular calcium elevations cause catecholamine resistance by uncoupling beta-receptors. American College of Chest Physicians, Boston, MA, November 1989.
  72. Zaloga GP, Prielipp R, Ward K. Plasma from patients with multiple-organ failure augments cellular calcium influx. American College of Chest Physicians, Boston, MA, November 1989.
  73. Rogers AT, Zaloga GP, Prough DS et al. Hyperglycemia during cardiac surgery: Central and peripheral mechanisms. International Anesthesia research Society, Honolulu, HI, March 1990.
  74. Butterworth JF, Royster RL, Robertie PG, Zaloga GP, et al. Hemodynamic effects of amrinone in patients recovering from aortocoronary bypass surgery. International Anesthesia Research Society, Honolulu, HI, March 1990.
  75. Zaloga GP, Sager A, Prielipp R, Ward K. Low dose calcium administration increases mortality during septic peritonitis. Annual Educational and Scientific Symposium, Society of Critical Care Medicine, San Francisco, CA, May 1990.
  76. Zaloga GP, Knowles R, Prielipp R, Ward K. Total parenteral nutrition (TPN) increases mortality following hemorrhage. Annual Educational and Scientific Symposium, Society of Critical Care Medicine, San Francisco, CA, May 1990.
  77. Prielipp RC, Zaloga GP, Butterworth JF, Robertie PG, Royster RL, Dudas LM, Ward KA. Magnesium inhibits the alpha but not the beta-adrenergic actions of epinephrine. 12th Annual Meeting of the Society of Cardiovascular Anesthesiologists, Orlando, FL, May 1990.
  78. Prielipp RC, Butterworth JF, Zaloga GP, Royster RL, Robertie PG, Dudas LM. Effects of amrinone on cardiac index, venous admixture, and mixed venous oxygen saturation in patients recovering from coronary artery bypass surgery. 12th Annual Meeting of the Society of Cardiovascular Anesthesiologists, Orlando, FL, May 1990.
  79. Zaloga GP, Prielipp RC, Ward KA. Total parenteral nutrition (TPN) increases mortality following methothrexate-induced endogenous sepsis. Meeting of the American Society of Anesthesiologists, Las Vegas, NV, October, 1990.
  80. Zaloga GP, Prielipp RC, Ward KA. The rate of enteral feeding is important for gut maintenance. Meeting of the American Society of Anesthesiologists, Las Vegas, NV, October 1990.
  81. Butterworth JF, Prielipp RC, Zaloga GP, Royster RL, Robertie PG. Is dobutamine less chronotropic than epinephrine after coronary artery surgery? Meeting of the American Society of Anesthesiologists, Las Vegas, NV, October 1990.
  82. Prielipp RC, Butterworth JF, Zaloga GP, Robertie PG, Royster RL. Amrinone increases venous admixture and decreases arterial oxygenation (PaO2) after coronary artery bypass graft surgery (CABG). Meeting of the American Society of Anesthesiologists, Las Vegas, NV, October 1990.
  83. Prielipp RC, Zaloga GP, Butterworth JF, Robertie PG, Royster RL. Magnesium inhibits the alpha-1 but not the beta-1 adrenergic actions of epinephrine in postoperative coronary artery bypass graft (CABG) patients. Meeting of the American Society of Anesthesiologists, Las Vegas, NV, October 1990.
  84. Zaloga GP, Sager A, Prielipp R, Ward K. Calcium administration decreases survival and exacerbates endotoxemia during peritonitis. American College of Chest Physicians, Toronto, Canada, October 1990.
  85. Zaloga GP, Ward K, Prielipp R. Peptide-based enteral diets stimulate body growth and IGF-1 production. American College of Chest Physicians, Toronto, Canada, October 1990.
  86. MacGregor DA, Scuderi PE, Bowton DL, Zaloga GP, Harris LE. A side-by-side comparison of four blood gas analyzers using tonometered human blood. American College of Chest Physicians, Toronto, Canada, October 1990.
  87. Zaloga GP, Prielipp RC, Black KW. Bacterial translocation does not explain the increased mortality produced by parenteral nutrition (TPN) following methotrexate. American Society of Parenteral and Enteral Nutrition, Fifteenth Clinical Congress, San Francisco, CA, January 1991.
  88. Zaloga GP, Prielipp R, Dudas L, Royster R, Butterworth J. Calcium impairs dobutamine's cardiovascular actions. Annual meeting of the Society of Critical Care Medicine, Washington, DC, May 1991.
  89. Bortenschlager L, Zaloga GP, Ward-Black K, Prielipp R. Immediate post-operative enteral feeding improves wound healing following abdominal surgery in rats. Annual meeting of the Society of Critical Care Medicine, Washington, DC, May 1991.
  90. Prielipp R, Zaloga GP, Dudas L, Black K. Bedside blood gas and electrolyte monitoring in critically ill patients. American Society of Anesthesiologists, San Francisco, CA, October 1991.
  91. Zaloga GP. Calcium antagonists improve survival during experimental sepsis: A meta-analysis. American College of Chest Physicians, San Francisco, CA, November 1991.
  92. Zaloga GP, Black KW, Prielipp R. Enteral feeding minimizes liver damage following hemorrhage. American College of Chest Physicians, San Francisco, CA, November 1991.
  93. Zaloga GP, Dudas L, Bortenschlager L, Roberts P, Black K, Prielipp R. Near-patient blood gas and electrolyte analyses are accurate when performed by non-lab trained individuals. American College of Chest Physicians, San Francisco, CA, November 1991.
  94. Zaloga GP, Bortenschlager L, Black K. Early postoperative administration of enteral or parenteral nutrition improves wound healing. American Society of Enteral and Parenteral Nutrition, Orlando, FL, January 1992.
  95. Zaloga GP, Meredith JW, Roberts P, Black K, Henningfield M. Improved hepatic protein responses with hydrolyzed protein versus intact protein diets after trauma. Annual Scientific and Educational Symposium, Society of Critical Care Medicine, San Antonio, TX, May 1992.
  96. Bortenschlager L, Black K, Zaloga GP. Human sepsis impairs lymphocyte slow calcium channel function. Annual Scientific and Educational Symposium, Society of Critical Care Medicine, San Antonio, TX, May 1992.
  97. Abernethy WB, Butterworth JF, Zaloga GP. Calcium entry attenuates adenyl cyclase activity. Ions Channels in the Cardiovascular System, Chantilly, VA, Sept 1992.
  98. Zaloga G, Roberts P, Black K, Prielipp R, Royster R, Butterworth J. The hemodynamic effects of calcium and dobutamine are additive in patients with sepsis. American Society of Anesthesiologists, New Orleans, LA, Oct 1992.
  99. Butterworth JF, Prielipp RC, Royster R, James R, Zaloga GP. A randomized, blinded comparison of dopexamine with dobutamine in patients with reduced cardiac output after coronary artery surgery. American Society of Anesthesiologists, New Orleans, LA, Oct 1992.
  100. Prielipp RC, Butterworth J, Pang J, Zaloga GP. Does calcium inhibit catecholamine action at B2 receptors by interfering with production of cyclic adenosine monophosphate? American Society of Anesthesiologists, New Orleans, LA, Oct 1992.
  101. Zaloga GP: Cardiovascular Effects of Glucagon. International Symposium on "Glucagon - Its Use in Emergency Medicine", Barcelona, Spain, Oct 1992.
  102. Roberts P, Black K, Zaloga G: Peptide-based enteral diets improve wound healing after abdominal surgery in rats. American Society for Parenteral and Enteral Nutrition, San Diego, CA, February 1993.
  103. Roberts P, Meredith JW, Black K, Zaloga G: Diarrhea does not alter impaired small bowel absorption following trauma. American Society for Parenteral and Enteral Nutrition, San Diego, CA, February 1993.
  104. Roberts P, Suleiman M, Black K, Zaloga G: Protein hydrolysates inhibit cyclic AMP generation: A mechanism for inhibition of secretory diarrhea. Annual Educational and Scientific Symposium, Society of Critical Care Medicine, New York, NY, June 1993.
  105. Roberts P, Black K, Zaloga G: Enteral nutrition improves survival and prevents bacterial dissemination following methotrexate. Annual Educational and Scientific Symposium, Society of Critical Care Medicine, New York, NY, June 1993.
  106. Roberts P, Black K, Zaloga G: Histidine infusion enhances free water clearance. American College of Chest Physicians, Orlando, FL, October 1993.
  107. Roberts P, Bortenschlager L, Black K, Zaloga G: Early enteral feeding minimizes liver injury following hemorrhage but not endotoxemia. American College of Chest Physicians, Orlando, FL, October 1993.
  108. Roberts P, Zaloga G, Black K: Histidine infusion enhances free water excretion by inhibiting cAMP generation in the kidney. American Society of Anesthesiologists, Washington, DC, October 1993.
  109. Zaloga GP, Abernethy WB, Butterworth JF: Calcium entry inhibits adenylyl cyclase activity: A mechanism for resistance to Beta-adrenergic agonists. American Society of Anesthesiologists, Washington, DC, October 1993.
  110. Zaloga G, Santamauro J, Roberts P, Klase E, Black K: Hand-held blood gas analyzer is accurate in the critical care setting. 23rd Educational and Scientific Symposium, Society of Critical Care Medicine, Orlando, FL, January 1994.
  111. Roberts P, Black K, Zaloga G: Early enteral feeding improves survival and decreases renal injury from rhabdomyolysis. 23rd Educational and Scientific Symposium, Society of Critical Care Medicine, Orlando, FL, January 1994.
  112. Roberts P, Black K, Zaloga G: Histidine enhances free water clearance and decreases urinary cAMP excretion. 23rd Educational and Scientific Symposium, Society of Critical Care Medicine, Orlando, FL, January 1994.
  113. Ririe DG, MacGregor DA, Butterworth JF, Royster RL, Zaloga GP: Direct inotropic effects of triiodothyronine in isolated hearts. Society of Cardiac Anesthsia, 1994.
  114. Ririe DG, Butterworth JF, Hines H, Hammon JW, Zaloga GP: Effects of cardiopulmonary bypass and deep hypothermic circulatory arrest on thyroid function during repair of congenital heart defects. Annual meeting of the American Society of Anesthesiologists, San Francisco, CA, Oct 1994.
  115. Roberts P, Black K, Zaloga GP: Small bowel absorption of bioactive peptides in rats: Implications for nutritional support. 24th Educational and Scientific Symposium of the Society of Critical Care Medicine, San Francisco, CA, Feb 1995.
  116. Roberts P, Suleiman K, Meredith JW, Zaloga GP: Early enteral nutrition is well tolerated in critically ill trauma patients: Advantages of small bowel feeding with concentrated formulas. 24th Educational and Scientific Symposium of the Society of Critical Care Medicine, San Francisco, CA, Feb 1995.
  117. Zaloga G, Suleiman K, Roberts P, Jain A, Meredith JW: Protein intake modulates glomerular filtration rate in trauma patients. 24th Educational and Scientific Symposium of the Society of Critical Care Medicine, San Francisco, CA, Feb 1995.
  118. Panacek EA, MacArthur RD, Johnson SB, Albertson TE, Maki D, Tobias J, Benjamin E, Zaloga G, Matuschak G, Silverstein J, Black G, for the T88 Sepsis Study Group. Results of a phase III Clinical Trial of the human monoclonal antibody MAB-T88 versus placebo in gram negative sepsis. 24th Educational and Scientific Symposium of the Society of Critical Care Medicine, San Francisco, CA, Feb 1995.
  119. Roberts PR, Black KW, Matheis E, Zaloga GP: Fiber based diet decreases bacterial adherence in the colon of rats. American Thoracic Society, Seattle, May 1995.
  120. Roberts PR, Black KW, Zaloga GP: Inotropic properties of the dietary peptide carnosine. American Thoracic Society. Seattle, May 1995.
  121. Roberts PR, Black KW, Zaloga GP: Acidosis does not impair cardiac function in the isolated rat heart. American Society of Anesthesiologists, Atlanta, Oct 1995.
  122. Zaloga SJ, Black KW, Roberts PR, Zaloga GP: Dietary peptide profile modulates body nitrogen utilization: implications for nutritional support. American Society of Anesthesiologists, Atlanta, Oct 1995.
  123. Roberts PR, Black KW, Zaloga GP: Early enteral feeding improves survival and renal function following muscle injury. American Society of Anesthesiologists, Atlanta, Oct 1995.
  124. Owen MD, Millington WR, Zaloga GP: Glycyl-l-glutamine, a beta-endorphin-derived peptide, restores blood pressure following acute hemorrhage in rats. American Society of Anesthesiologists, Atlanta, Oct 1995.
  125. Roberts PR, Zaloga GP, Black KW: Inotropic actions of the dietary peptide carnosine are not mediated via the beta-adrenergic receptor. Society of Critical Care Medicine, New Orleans, Louisiana, Feb 1996, A30.
  126. Roberts PR, Zaloga GP, Black KW: Gastrointestinal absorption of bioactive proteins: Implications for dietary modulation of organ function. Society of Critical Care Medicine, New Orleans, Louisiana, Feb 1996, A40.
  127. Roberts PR, Black KW, Zaloga GP: Enteral carnosine supplementation improves wound healing in rats after surgery. Society of Critical Care Medicine, New Orleans, Louisiana, Feb 1996, A111.
  128. Zaloga GP, Roberts P, Black K: Nitric oxide inhibition exacerbates the myocardial depressant effects of phenylpropanolamine (PPA). American Society of Anesthesiologists, New Orleans, October 1996.
  129. Roberts P, Nakayama M, Black K, Zaloga G, Nelson T: Decreased cardiac carnosine levels may contribute to myocardial dysfunction in sepsis. American Society of Anesthesiologists, New Orleans, October 1996.
  130. Ririe D, Tong C, Zaloga G: The dietary dipeptide carnosine causes vascular relaxation. American Society of Anesthesiologists, New Orleans, October 1996.
  131. Roberts P, Zaloga G, Black K, Lin M, Zapata-Sudo G, Sudo RT, Nelson TE: Carnosine’s inotropic actions are mediated via changes in intracellular calcium. American Society of Anesthesiologists, New Orleans, October 1996.
  132. Zaloga SJ, Roberts PR, Black KW, Burney JD, Zaloga GP: Antibacterial properties of wine: Potential role for nutritional support. Society of Critical Care Medicine, San Diego, California, Feb 1997.
  133. Zaloga GP, Roberts PR: The dietary peptide carnosine improves myocardial contractility following endotoxin administration. The 7th World Congress of Intensive and Critical Care Medicine, Ottawa, Canada, July 1997.
  134. Roberts PR, Zaloga GP: Dietary nutrients block bacterial adherence to colonic mucosa. The 7th World Congress of Intensive and Critical Care Medicine, Ottawa, Canada, July 1997.
  135. Roberts PR, Black KW, Zaloga GP: Effect of fasting and refeeding on renal blood flow: Implications for perioperative management. American Society of Anesthesiologists, San Diego, California, October 1997.
  136. Roberts PR, Black KW, Zaloga GP: Short-term continuous enteral feeding improves renal blood flow. 27th Society of Critical Care Medicine Educational and Scientific Symposium, San Antonio, Texas, February 1998.
  137. Zaloga SJ, Roberts PR, Burney JD, Black KW, Zaloga GP: Immune enhancing formulas produce different anabolic effects. 27th Society of Critical Care Medicine Educational and Scientific Symposium, San Antonio, Texas, February 1998.
  138. Roberts PR, Zaloga GP: Wine inhibits enterotoxin-induced secretory diarrhea. 27th Society of Critical Care Medicine Educational and Scientific Symposium, San Antonio, Texas, February 1998.
  139. Roberts PR, Black KW, Zaloga GP: Enteral nutrition blunts decrease in mesenteric blood flow during high dose phenylephrine administration. Society of Critical Care Medicine, San Francisco, California, Jan 1999.
  140. Marik PE, Lynott J, Croxton M, Palmer E, Miller LE, Zaloga GP: The effect of blind-protected specimen brush (B-PSB) sampling on antibiotic usage in patients with suspected ventilator associated pneumonia (VAP). Society of Critical Care Medicine, Orlando, Florida, Feb 2000.
  141. Todd N, Marik PE, Zaloga GP: Bolus versus continuous gastric nutrient administration: efficacy and risk for pneumonia in critically ill patients. Society of Critical Care Medicine, Orlando, Florida, Feb 2000.
  142. Higgins TL, Murray MJ, Kett DH, et al: Trace metal elimination during continuous sedation with propofol containing EDTA in critically ill patients. Society of Critical Care Medicine, Orlando, Florida, Feb 2000.
  143. Marik PE, Zaloga GP: Hypothermia and cytokines in septic shock. Society of Critical Care Medicine, Orlando, Florida, Feb 2000.
  144. Marik PE, Kiminyo K, Olexo S, Zaloga GP: Occult adrenal insufficiency (AI) in critically ill patients: an underdiagnosed entity. Society of Critical Care Medicine, Orlando, Florida, Feb 2000.
  145. Zaloga GP, Teres D, Das R: Critical illness is associated with elevated parathyroid hormone. International Symposium on Intensive Care and Emergency Medicine. Brussels, March 2001.
  146. Zaloga GP, Das R, Youngs E, Teres D: Short-term propofol sedation increases serum levels of parathyroid hormone independent of calcium levels in normal subjects. International Symposium on Intensive Care and Emergency Medicine. Brussels, March 2001.
  147. Marik PE, Rotello L, Zaloga GP: Secondary adrenal insufficiency is common in critically ill patients. Society of Critical Care Medicine, San Diego, CA, January 2002.
  148. Siddiqui R, Wiesehan J, Hunter M, Harvey K, Zaloga GP: Docosahexaenoic acid induces cell cycle arrest via hypophosphorylation of human retinoblastoma protein in Jurkat leukemic cells. Fifth congress of the International Society for the Study of Fatty Acids and Lipids, Montreal, Canada, May 2002.
  149. Siddiqui RA, Hunter M, Zaloga GP, Stillwell W: Docosahexaenoic acid prevents phenylephrine-induced cardiac hypertrophy through ras-raf-MAP kinase pathway. Fifth congress of the International Society for the Study of Fatty Acids and Lipids, Montreal, Canada, May 2002.
  150. Zaloga GP, Siddiqui R, Hunter M, Stillwell W: Omega-3 long chain fatty acids inhibit pathologic hypertrophy of cardiomyocytes by modulating activation of protein kinase C. American College of Chest Physicians, San Diego, CA, November 2002.
  151. Siddiqui RA, Jenski LJ, Harvey KA, Wiesehan JD, Stillwell W, Zaloga GP: Docosahexaenoic acid induces cell cycle arrest by inhibiting phosphorylation of Retinoblastoma protein in Jurkat leukemic cells. 37th Annual Southeastern Regional Lipid Conference, Cashiers, NC, November 2002.
  152. Roberts PR, Zaloga GP, and the immune formula study comparison group: Comparison of two immune-modulating formulas: A randomized multicenter trial. American Thoracic Society (to be presented)

TV and VIDEOS:

  1. VIDEO: Near Patient Testing: A Partnership for Quality Care. American Association for Clinical Chemistry and Eastman Kodak Company. December 1992.
  2. VIDEO: Peptides: A New Perspective. Clintec Nutrition. November 1993.
  3. VIDEO: Advantages of small peptides for nutritional support. Healthwatch 90 Video Program. 1994.
  4. TV: Diet pills. Eye-to-Eye with Connie Chung, January 1995.
  5. TV: Migraine Headaches and Sumatriptan, World News Tonight with Peter Jennings (American Agenda), April 1996.

Visiting Professorships and Invited Lectureships:

  1. "Calcium and Magnesium." Symposium on the Pharmacologic Approach to the Critically Ill Patient. Sponsored by the Critical Care Medicine Department, Bethesda Naval Hospital, Uniformed Services University of the Health Sciences, and Association of Military Surgeons of the United States. Bethesda, MD, September 1983.
  2. "New Trends in Calcium Metabolism." Suburban Hospital Association, Bethesda, MD, August 1984.
  3. "Thyroid Disease in Pregnancy," "Intensive Care of Patients with Adult Respiratory Distress Syndrome and Disseminated Intravascular Coagulation," and "Massive Hemorrhage in Obstetrics." Continuing Health Education Program in Obstetrics and Gynecology. West Berlin, Germany, November 1984.
  4. "Updates in Calcium Metabolism." Capital Hill Hospital, Washington, DC, January 1985.
  5. "Hypercalcemic and Hypocalcemic States - Clinical Interpretations and Implications for Management" and "Case Studies in Hypoglycemia and Hyperglycemia." Critical Care Medicine 23rd Annual Symposium, Las Vegas, NV, February 1985.
  6. "Electrolyte Disorders" and "Thyroid Abnormalities." Continuing Medical Education Program, Uniformed Services University of the Health Sciences; Yokosuka, Japan; Subic Bay, Phillipines; Guam, July 1985.
  7. "Vitamin Deficiencies" and "Electrolyte Disorders." Georgetown University School of Medicine, Clinical Nutrition Course, Washington, DC, September 1985.
  8. "Nutritional Assessment and Enteral Nutrition with Special Application to Critical Care Medicine" and "Electrolyte and Selected Trace Mineral Metabolism with Special Application to Critical Care Medicine." Selected Topics in Human Nutrition, FAES Graduate School, National Institutes of Health, Bethesda, MD, October 1985.
  9. "Treatment of Pulmonary Hypertension." Postgraduate Course on Respiratory Therapy. Fourth Argentine Congress on Intensive Care. Rosario, Argentina, October 1985.
  10. "Hypophosphatemia, Hypo and Hypermagnesemia" and "Opioid Peptides in Shock." Postgraduate Course on Endocrine-Metabolic Alterations in Intensive Care. Fourth Argentine Congress of Intensive Care. Rosario, Argentina, October 1985.
  11. "Thyrotoxic Storm." Minicourse on Non-Diabetic Endocrine Emergencies. Fourth Argentine Congress of Intensive Care. Rosario, Argentina, October 1985.
  12. "Thyroidal Alterations in the Critically Ill," "Glucagon - Its Use in Intensive Care," and "Hypocalcemia in the Critically Ill Patient." Fourth Argentine Congress of Intensive Care. Rosario, Argentina, October 1985.
  13. "Mineral Abnormalities in the Critically Ill Patient." Anesthesia Grand Rounds. Children's Hospital National Medical Center, Washington, DC, January 1986.
  14. "Frontiers in the Pharmacotherapy of Shock" and "Clinical Significance of Endocrine Alterations in the Critically Ill." Thirty-Seventh Annual Postgraduate Program, Critical Care Medicine, Roanoke Memorial Hospitals, Roanoke, VA, March 1986.
  15. "Frontiers in the Pharmacotherapy of Shock." Internal Medicine Grand Rounds, Washington Hospital Center, Washington, DC, April 1986.
  16. "Practical Suggestions for ICU Bedside Care - Hypocalcemia." Society of Critical Care Medicine Annual Scientific and Educational Symposium, Washington, DC, May 1986.
  17. "Calcium in Shock." Bowman Gray School of Medicine, Winston-Salem, NC, October 1986.
  18. "Calcium homeostasis during sepsis." Wayne State University School of Medicine, Harper Hospital and Hutzel Hospital, Detroit, MI, April 1987.
  19. "Sympathetic nervous system alterations during sepsis." Wayne State University School of Medicine, Harper Hospital, Detroit, MI, April 1987.
  20. "Thyroid and Adrenal Crisis and Hypothermia in the ICU" and "Endocrine Electrolyte Abnormalities - Ca, Mg, PO4." American College of Physicians, Critical Care Review Course, New York, NY, June 1987.
  21. "Management of Patients with Sepsis," "New Directions in Shock Therapy," "Management of Adult Respiratory Distress Syndrome," and "The Use of Hormones During Critical Illness." Visiting Professor, Hospital Central De Las FF.AA, Montevideo, Uruguay, September 1987.
  22. "Endocrine aspects of Critical Illness." Baystate Medical Center, University of Massachusetts, Springfield MA, September 1987.
  23. "Pathophysiology of Septic Shock in Relationship to Calcium Metabolism." Annual Meeting of the American Society of Anesthesiologists, Atlanta, GA, October 1987.
  24. "Endocrine abnormalities in ICU Patients." Annual Meeting of the American College of Chest Physicians, Atlanta, GA, October 1987.
  25. "Electrolyte Monitoring." Meeting sponsored by Diamond Sensor Systems, Vail, CO, January 1988.
  26. "Hypothyroidism and the sick-euthyroid syndrome" and "Potassium disorders." Critical Care Medicine '88. Sponsored by the Regional Medical Center, Orlando , FL, April 1988.
  27. "Endocrine emergencies". Current Concepts in Critical Care. Sponsored by The Carolina/Virginia Society of Critical Care Medicine, Asheville, NC, April 1988.
  28. "Calcium, Phosphorus, and Magnesium Abnormalities," "Sodium and Potassium Disorders," "Endocrine Emergencies - Thyroid and Adrenal," "Calcium and Sepsis," "ICU Nutrition," "Hemodynamic Effects of Calcium." Naval Hospital and Uniformed Services University, Bethesda, MD, July 1988.
  29. "Nutritional Support for the Critically Ill Patient." Memorial Hospital, Mount Holly, NJ, September 1988.
  30. "Calcium and Magnesium Metabolism in the ICU" and "Thyroid and Adrenal Crisis in the ICU." Intensive Care Medicine 1989, sponsored by the American College of Physicians, New York, NY, October 1988.
  31. "Endocrine abnormalities in ICU patients." Critical Care Medicine (23rd Annual Macklin Lecture Series sponsored by Naval Hospital Portsmouth), Portsmouth, VA, October 1988.
  32. "Nutrition in the critically ill." Medical College of Virginia, Richmond, VA, December 1988.
  33. "Enteral versus parenteral nutrition in the critically ill," "Endocrine emergencies," "Catecholamine resistance." Mayo Clinic, Rochester, MN, January 1989.
  34. "Nutrition for the traumatized patient." Georgia Baptist Hospital, Atlanta, GA, January 1989.
  35. "Frontiers in nutrition." Crawford-Long Hospital, Atlanta, GA, January 1989.
  36. "Nutrition in the critically ill." The Bowman Gray School of Medicine, Winston-Salem, NC, February 1989.
  37. "Nutrition in the critically ill--enteral vs. parenteral." Surgery Grand Rounds, University Hospital, Medical University of South Carolina, Charleston, SC, February 1989.
  38. "Enteral nutrition in the critically ill." Combined Surgery and Medicine Seminar, Roper Hospital, Medical University of South Carolina, Charleston, SC, February 1989.
  39. "Nutrition and the traumatized patient." Cuyahaga Falls General Hospital, Cuyahaga Falls, OH, March 1989.
  40. "Nutrition in the critically ill patient." Gaston Hospital, Gastonia, NC, March 1989.
  41. "Nutrition in the critically ill." Mount Sinai and St. Luke's-Roosevelt Hospitals, New York City, NY, March 1989.
  42. "Diabetic Ketoacidosis and Hyperosmolar Crisis" and "ICU management of Diabetes Insipidus and the Syndrome of Inappropriate Antidiuresis." 16th Annual Critical Care Medicine Conference sponsored by Orlando Regional Medical Center, Orlando, FL, March 1989.
  43. "Nutrition in the critically ill patient." Naval Hospital, San Diego, CA, April 1989.
  44. "Frontiers in critical care nutrition." Harborview Hospital and University of Washington Hospital, Seattle, WA, April 1989.
  45. "Nutrition in the critically ill--enteral nutrition and organ failure." Surgery Grand Rounds, Washington Hospital Center, Washington, DC, April 1989.
  46. "Calcium and the heart." Intensive Care Medicine--from metabolism to monoclonals, 16th Annual Harvard Course, sponsored by Massachusetts General Hospital, Boston, MA, April 1989.
  47. "Nutrition in the critically ill patient." Naval Hospital, Bethesda, MD, April 1989.
  48. "Nutrition following trauma and critical injury." Charlotte Memorial Hospital, Charlotte, NC, April 1989.
  49. "Nutrition in the critically ill." University of West Virginia Medical Center, Charleston, WV, May 1989.
  50. "Nutrition and organ function." Bethany Medical Center, Kansas City, KS, May 1989.
  51. "Prevention of endogenous infections." The First Consensus Development Conference on the Treatment of Radiation Injuries, Washington, DC, May 1989.
  52. "Principles of nutrition." Charlotte Memorial Hospital, Charlotte, NC, May 1989.
  53. "Endocrine emergencies." Sunrise Session, 18th Annual Educational and Scientific Symposium, Society of Critical Care Medicine, New Orleans, LA, June 1989.
  54. "Gut-origin sepsis: effect of enteral nutrition." University of Minnesota, Minneapolis, MN, June 1989.
  55. "Nutrition in the critically ill patient." Harris Hospital and St. Joseph's Hospital, Fort Worth, TX, July 1989.
  56. "Nutrition, sepsis, and organ function." Orlando Regional Medical Center, Orlando, FL, July 1989.
  57. "Nutrition, sepsis, and organ function." Tampa General Hospital, Tampa, FL, July 1989.
  58. "Nutrition in the critically ill." North Trident Regional Medical Center, Charleston, SC, August 1989.
  59. "Nutrition and sepsis." Charleston Naval Hospital, Charleston, SC, August 1989.
  60. "Nutrition and critical illness." Waukesha Memorial Hospital and Sinai-Samaritan Medical Center, Milwaukee, WI, August 1989.
  61. "Critical care nutrition." St. Thomas Medical Center and Timken Mercy Medical Center, Akron, OH, August 1989.
  62. "Gut-origin sepsis." Walter Reed Army Medical Center, Washington, DC, September 1989.
  63. "Enteral vs. parenteral nutrition in the critically ill patient." Arlington Hospital, Arlington, VA, September 1989.
  64. "Enteral nutrition in the critically ill." University of Alabama, Montclair Baptist Hospital, Birmingham, AL, September 1989.
  65. "Enteral vs. parenteral nutrition in the critically ill." Tulane Medical Center, New Orleans, LA, September 1989.
  66. "Nutrition in the critically ill patient." Kessler Air Force Base Medical Center, Biloxi, MS, September 1989.
  67. "Fluid, electrolyte and acid-base balance in critically ill patients." Current Concepts in Nutrition Support, Sponsored by Grady Memorial Hospital, Atlanta, GA, September 1989.
  68. "Enteral versus parenteral nutrition in the surgical patient." St. Joseph Hospital, Houston, TX, September 1989.
  69. "Nutrition in the critically ill." University of Texas Medical Branch at Galveston, Galveston, TX, September 1989.
  70. "Enteral versus parenteral nutrition." Marshall University School of Medicine, Huntington, WV, September 1989.
  71. "Nutrition in the critically ill: enteral vs. parenteral." Pitt County Memorial Hospital, East Carolina Medical School, Greenville, NC, September 1989.
  72. "Gut origin sepsis." Metabolic Support and Management of the Critically Ill Patient (sponsored by the University of Tennessee Medical Center at Knoxville), Asheville, NC, October 1989.
  73. "Early tube feeding vs. TPN in the critically ill." M.A.S.P.E.N., Charlotte, NC, October 1989.
  74. "Clinical Needs and Benefits of Decentralized Testing", Sponsored by Mallinckrodt Sensor Systems, Meeting of the American Society of Clinical Pathologists, Washington, DC, November 1989.
  75. "Endocrine Problems in the Critically Ill" and "Nutrition in the Critically Ill", Care of the Critically Ill and Injured, Sponsored by the Medical University of South Carolina, Charleston, SC, November 1989.
  76. "Advances in Enteral Nutrition", St. Joseph's Hospital, Asheville, NC, December 1989.
  77. "Advances in Nutrition", St. Vincent's Hospital, University Hospital, and Memorial Hospital, Jacksonville, FL, December 1989.
  78. "Nutrition in the Critically Ill Patient", Presbyterian Hospital, Charlotte, NC, December 1989.
  79. "Nutrition and Prevention of Organ Function", Howard University, Washington, D.C. and Naval Hospital, Bethesda, MD, January 1990.
  80. "Gut Growth Factors and Prevention of Infection in Critically Ill Patients", Good Samaritan Regional Medical Center and Veterans Administration Medical Center, Phoenix, AZ, January 1990.
  81. "Electrolyte abnormalities in acute illness" and "Oral alimentation in nutrition", Robert Wood Johnson Medical School, University of Medicine and Dentistry of New Jersey, New Brunswick, NJ, January 1990.
  82. "Critical Care Nutrition", Fairview General Hospital, Cleveland, OH, February 1990.
  83. "Nutrition in the Critically Ill", Baylor College of Medicine, Houston, TX, February 1990.
  84. "Nutrition in the Critically Ill", Greater Southeast Hospital Washington, DC, March 1990.
  85. "Nutrition in the Critically Ill Patient", Humana Heart Institute, Louisville, KY, March 1990.
  86. "Physiologic Effects of peptides" and "Parenteral vs Enteral Nutrition in the Critically Ill Patient", Humana Hospital, University of Louisville School of Medicine, Louisville, KY, March 1990.
  87. "Nutrition and organ failure", Gaston Memorial Hospital, Gastonia, NC, March 1990.
  88. "The importance of early enteral feeding in the critically ill", St. Francis Medical Center, Tapica, KS, March 1990.
  89. "Nutrition and prevention of organ failure", Medical College of Georgia, Augusta, GA, March 1990.
  90. "The perioperative management of the patient with pheochromocytoma", 31st Annual New Jersey Postgraduate Anesthesia Seminar, Cherry Hill, NJ, March 1990.
  91. "Problems and Benefits from Enteral Nutrition" and "Problems and Benefits from TPN", Current Management in Critical Care sponsored by the Kansas City Southwest Clinical Society, Kansas City, MS, April 1990.
  92. . "Special nutritional problems in the ICU", LSU School of Medicine, New Orleans, LA, April 1990.
  93. "Enteral vs parenteral nutrition in the critically ill patient", Methodist Hospital, New Orleans, LA, April 1990.
  94. "Enteral nutrition in the critically ill patient", Forest General Hospital, Hattiesburg, MS, April 1990.
  95. "Nutritional support in the critically ill", St. Elizabeth's Hospital, Elizabeth, NJ, May 1990.
  96. "Update in nutrition for the critically ill patient", Charleston Area Medical Center, Charleston, West Virginia and VA Medical Center, Huntington, WV, May 1990.
  97. "Metabolic causes of respiratory failure", Annual educational and scientific symposium, Society of Critical Care Medicine, San Francisco, CA, May 1990.
  98. "Nutritional support of the critically ill patient", St. Mary's Regional Medical Center, Reno, NV, May 1990.
  99. "Parenteral and enteral nutrition in the critically ill", Loma Linda University, Loma Linda, CA, June 1990.
  100. "Update in nutritional support in the critically ill patient", St. Jude's Hospital, Fullerton, CA, June 1990.
  101. "Update in nutritional support in critically ill patients", Naval Hospital, San Diego, CA, June 1990.
  102. "New concepts in nutritional support", Children's Hospital, San Diego, CA, June 1990.
  103. "Fluid and electrolyte balance" and "Clinical studies with hormone regulators", Postgraduate course on "Research and Clinical Applications in Nutrition Support: Immunity, Hormone Regulation and Lipids". Sponsored by the American Society of Parenteral and Enteral Nutrition and the Georgia Society for Parenteral and Enteral Nutrition, Atlanta, GA, June 1990.
  104. "Nutritional modulation of growth and repair in the critically ill patient", Marriott Clinical Update, Alexandria Hospital, Alexandria, VA, July 1990.
  105. "Bedside laboratory testing". American Association of Clinical Chemists, San Francisco, CA, July 1990.
  106. "Nutritional Support in the Neurologically Injured Patient." University of Florida School of Medicine, Gainsville, FL, July 1990.
  107. "Enteral Nutrition in the Critically Ill." Memorial Hospital, Jacksonville, FL, July 1990.
  108. "Critical Care Nutrition: Parenteral vs Enteral Nutrition." Stark County Dietetic Association and Aultman Hospital, Canton, OH, September 1990.
  109. "Nutritional Considerations in Critical Care Medicine". Advances in Critical Care Medicine, sponsored by the University of Tennessee, Memphis, TN, September 1990.
  110. "Nutrient Effects on Metabolic Function", "Case Studies of Enteral Nutrient Delivery", and "Clinical Usefulness of Glutamine!". Fall Postgraduate Course entitled, "The technology of Nutrition Support: From Bench to Bedside", sponsored by the American Society for Parenteral and Enteral Nutrition and the Ohio Society for Parenteral and Enteral Nutrition, Cleveland, OH, September 1990.
  111. "Early Enteral Feeding." Course entitled, Care of the Critically Ill Patient, sponsored by the Northern Virginia Consortium for Continuing Medical Education, Alexandria, VA, September 1990.
  112. "Enteral vs Parenteral Nutrition in the Critically Ill". Cedar Sinai Hospital, Los Angeles, CA, September 1990
  113. "Parenteral vs Enteral Nutrition in the Critically Ill". Medical College of Pennsylvania and Frankford Hospital, Philadelphia, PA, September 1990.
  114. "Nutrition and organ function". Baptist Hospital, Montgomery, AL, October 1990.
  115. "The vital role of the gastrointestinal tract in maintaining immunocompetence and preventing sepsis in critically ill or injured patients". Medical seminar on Radiation and Health, Penn State College of Medicine, Berwick, PA, October 1990.
  116. "Enteral vs TPN: Nutrition in the critically ill." Craven-Pamlico-Jones Medical Society, New Bern, NC, October 1990.
  117. "Nutrition in the Critically Ill and Traumatized Patient." New Hanover Hospital, Wilmington, NC, November 1990.
  118. "Nutrition and organ function", Memorial Sloan-Kettering Cancer Center, New York, NY, November 1990.
  119. "Early enteral nutrition in the critically ill patient", St. Joseph Hospital and Methodist Hospital, Houston, TX, December 1990.
  120. "Early enteral nutrition in the critically ill patient", Independence Regional Health Center, Independence, MO, December 1990.
  121. "Metabolic response to stress: Implications for nutritional support", Lexington Medical Center and Richland Memorial Hospital, Columbia, SC, January 1991.
  122. "Endocrine Problems in the Critically Ill" and "Septic Shock: Fluid and Drug Management", South Carolina Association of Nurse Anesthetists State Meeting, Columbia, SC, February 1991.
  123. "Metabolic Resuscitation/Nutritional Support of the Head Injury Patient", Neurotrauma Clinical Symposium, University of North Carolina at Chapel Hill, School of Nursing, Research Triangle Park, NC, February 1991.
  124. "Nutrition and prevention of systemic infection", Annual meeting of the Society of Critical Care Medicine, Washington, DC, May 1991.
  125. "The Endocrine System", "Electrolyte Problems in the Critically Ill", "Critical Care Nutrition", and "Shock", Tenth Annual St. Petersburg Beach Symposium on Critical Care, St. Petersburg, FL, June 1991.
  126. "Monitoring versus Testing Technologies", American Association of Clinical Chemistry Workshop, Washington, DC, July 1991.
  127. "The Endocrine System", "Electrolyte Disorders", "Nutrition in the Critically Ill", "Shock", Critical Care Nursing Symposium, Myrtle Beach, SC, August 1991.
  128. "Enteral Feeding - Friend or Foe?", Critical Care Nursing Program, 9th Annual Symposium, Kansas City, MO, August 1991.
  129. "Enteral Therapy in 1991", Bethany Medical Center, Kansas City, KS, August 1991.
  130. "Monitoring versus Testing Technologies", Clinical Laboratory Management Association, Atlanta, GA, September 1991.
  131. "Nutritional support of the critically ill patient", University of Kentucky, Lexington, KY, October 1991.
  132. "Nutritional support of critically ill patients", Saint Vincent Hospital, Worcester, MA, October 1991.
  133. "Timing and route of nutritional support in the critically ill", Boston University Medical Center, Boston, MA, October 1991.
  134. "Endocrine and electrolyte abnormalities", "Circulatory Shock", Nutrition in the ICU", Critical Care Nursing Symposium, Asheville, NC, October 1991.
  135. "Enteral Nutrition in the ICU", University of North Carolina at Chapel Hill, Chapel Hill, NC, October 1991.
  136. "Nutritional Support in the Critically Ill", Henry Ford Hospital and Harper Hospital, Detroit, MI, December 1991.
  137. "Enteral Nutrition in the Critically Ill Patient", Rhode Island Hospital and Kent County Hospital, Providence, RI, December 1991.
  138. "Calcium-catecholamine Interactions in Sepsis" and "Current Status of Nutritional Therapies", St. Francis Medical Center, Pittsburgh, PA, January 1992.
  139. "Peptide Pep-Rally and Fat Formations", Georgia Society of Parenteral and Enteral Nutrition, Atlanta, GA, January 1992.
  140. "Nutritional Support of the Critically Ill Patient", Georgia Baptist Hospital and Emory University Hospital, Atlanta, GA, January 1992.
  141. "Update in Nutritional Support for the Critically Ill Patient", Providence Hospital and Washington Hospital Center, Washington, DC, February 1992.
  142. "Nutritional Support of the Critically Ill Patient" and "Protein in the Diet: Peptides, Glutamine, Arginine", Princeton Medical Center, University of Alabama-Birmingham Medical Center, and Carraway Medical Center, Birmingham, AL, February 1992.
  143. "Nutritional Support of the Critically Ill Patient" and "Assessment of Home Dietary Needs of the Pulmonary Patient", Omaha Pulmonary Symposium, Omaha, NE, February 1992.
  144. "Peptides in Nutrition Support", Contemporary Issues in Nutrition Support sponsored by The Western New York Consortium for Nutrition Support, Buffalo, NY, March 1992.
  145. "Endocrine Emergencies", Carolinas Medical Center, Charlotte, NC, March 1992.
  146. "Calcium in the treatment of Shock" and "Current trends in nutrition/metabolic support of the critically ill patient", Cooper Hospital University Medical Center, University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School at Camden, Camden, NJ, May 1992.
  147. "Calcium in the treatment of Shock" and "Current trends in nutrition/metabolic support of the critically ill patient", Fairfax Hospital, Fairfax, VA, May 1992.
  148. "Endocrine dysfunction in the critically ill", "Electrolyte Disorders", "Update in the treatment of shock", "Nutrition", Eleventh Annual St. Petersburg Beach Seminar, St. Petersburg, FL, June 1992.
  149. "Endocrine dysfunction in the critically ill", "Electrolyte Disorders", "Update in the treatment of shock", "Nutrition", Critical Care, Reno, NV, June 1992.
  150. "Enteral Nutrition in the Critically Ill Patient", St. Mary's Medical Center, Reno, NV, June 1992.
  151. "Multiple Organ Failure: Effect of Enteral Nutrition", Annual Meeting of the Georgia Dietetic Association, Atlanta, GA, July 1992.
  152. "Early Enteral Feeding", Mt. Carmel Medical Center, Columbus, OH, August 1992.
  153. "Endocrine Dysfunction in the Critically Ill", "Electrolyte Disorders", "Update in the treatment of shock", "Nutritional Support", Critical Care Conference, Myrtle Beach, SC, August 1992.
  154. "Nutrition Support in Inflammatory Bowel Disease", Third Annual Columbus Day Nutrition Support Symposium, Santa Barbara, California, October 1992.
  155. "Nutrition Support, Immunity, and MSOF", Nutrition Support Symposium, University of Virginia, Charlottesville, Virginia, December 1992.
  156. "Enteral vs. Parenteral Feeding: The Changing View of TPN - What is the Role of Immune-Enhancing Enteral Formulas?, Controversies in Critical Care, Sponsored by the Society of Critical Care Medicine, Maui, Hawaii, January 1993.
  157. "Nutrition in the Critically Ill Patient", Bristol Regional Medical Center, Bristol, TN, January 1993.
  158. "Enteral Nutrition in the Critically Ill Patient", St. Francis Regional Medical Center, Wichita, Kansas, February 1993.
  159. "Designer Diets - Peptides, Arginine, Glutamine, Omega-3 fatty acids", Naval Hospital, San Diego, California, February 1993.
  160. "Enteral Versus Parenteral Feeding", Round Table Conference on Metabolic Support of the Critically Ill Patient, Brussels, Belgium, March 1993.
  161. "Parenteral Versus Enteral Nutrition", "When and How I Start Enteral Nutrition", "Should We Correct Hypocalcemia in the Critically Ill?", 13th International Symposium on Intensive Care and Emergency Medicine, Sponsored by the European Society of Intensive Care Medicine and World Federation of Societies of Intensive Care, Brussels, Belgium, March 1993.
  162. "Critical Care Nutrition" and "Effects of Nutrition Support on the Immune System", Nutrition Support in the Critically Ill Patient, Tallahasse Memorial Hospital, Tallahasse, Florida, April 1993.
  163. "Advances in Nutrition Support", Baylor School of Medicine, Houston, Texas, April 1993.
  164. "Nutrition in the Critically Ill Patient", University of Texas Medical Center, Houston, Texas, April 1993.
  165. "Early Enteral Nutrition in the Critically Ill" and "Designer Diets", South Florida Pediatric Critical Care Symposium, Ft. Lauderdale, Florida, April 1993.
  166. "The Effects of Nutrients in Immune Function" and "Calcium-Catecholamine Interactions", 13th Critical Care Medicine Series, Orlando Regional Healthcare System, Lake Buena Vista, Florida, April 1993.
  167. "Nutrition and Cell Function in Sepsis", Infection and the Critically Ill Patient, Society of Critical Care Medicine, Chicago, Il, April 1993.
  168. "Enteral vs Parenteral Nutrition" and "Vasoactive Drugs for Hypertensive Crisis: Is the Nipride Era Coming to an End", Controversies in Critical Care, Society of Critical Care Medicine, Cancun, Mexico, April 1993.
  169. "Calcium and Magnesium Therapy: Are they indicated?" and "Nutritional Management of the Critically Ill Patient", Northwestern University Medical Center, Chicago, Il, May 1993.
  170. "Nutrition, Cytokines and Infection", American Thoracic Society, San Francisco, California, May 1993.
  171. "Advances in Arterial Blood Gas Monitoring of the Critically Ill Patient" and "Thyroid Hormone Therapy in the ICU", Annual Educational and Scientific Symposium, Society of Critical Care Medicine, New York, NY, June 1993.
  172. "Sepsis", "Acute Renal Failure", "Asthma", Diabetes Mellitus", "Management of the bleeding patient", Nursing Conference, Clearwater, Florida, June 1993.
  173. "Nutrition and Cell Function in Sepsis", Infection and the Critically Ill Patient, Society of Critical Care Medicine, San Francisco, California, July 1993.
  174. "Sepsis", "Acute Renal Failure", "Asthma", Diabetes Mellitus", "Management of the bleeding patient", Nursing Conference, Destin, Florida, July 1993.
  175. "Endocrine Emergencies", "Diabetic Ketoacidosis", "Nutrition", Critical Care Review Course, Society of Critical Care Medicine, Atlanta, Georgia, August 1993.
  176. "Enteral and Parenteral Nutrition in the Critically Ill Patient", Northwest Chapter of the American Society of Enteral and Parenteral Nutrition, Tacoma, Washington, September 1993.
  177. "Early Enteral Nutrition in the Critically Ill Patient", Blodgett Hospital, Grand Rapids, Michigan, October 1993.
  178. "Disease Specific Nutritional Formulas", The First International Critical Care Symposium on the Niagara Frontier, Niagara Falls, New York, October 1993.
  179. "Early Refeeding/Nutrition Intervention", Nutrition and the Critically Ill Patient, Fairfax Hospital, Fairfax, Virginia, Oct 1993.
  180. "Monitoring of Nutrition Support" and "Enteral versus Parenteral Nutrition In The Critically Ill Patient", American College of Chest Physicians, Orlando, Florida, Nov 1993.
  181. "Early Enteral Feeding: Improved Outcome", St. Jude Medical Center, Fullerton, California, Nov 1993.
  182. "Septic Shock: Current Concepts and Therapy" and "Nutrition in the Critically Ill Patient: A Different Perspective", Anesthesiology and Critical Care Update 1993, University of Florida, Orlando, Florida, Nov 1993
  183. "Immune Enhancing Formulas: Do they make a difference?" and "Vasoactive Drugs: Is the Nipride Era Coming to an End?", Controversies in Critical Care, Society of Critical Care Medicine, Phoenix, Arizona, Nov 1993
  184. "Sepsis", "Acute Renal Failure", "Asthma", "Diabetes Mellitus", "Management of the bleeding patient", Nursing Conference, Orlando, Florida, Dec 1993.
  185. "Critical Electrolyte Disorders" and "Nutrient Modification of Cytokine Responses", 23rd Educational and Scientific Symposium, Society of Critical Care Medicine, Orlando, Florida, January 1994.
  186. "Nutrition and the Critically Ill Patient", Trinity Lutheran Hospital, Kansas City, MO, February 1994.
  187. "Nutritional Support of the Critically Ill Patient", St. Joseph's Medical Center, Phoeniz, AZ. February 1994.
  188. "Early Enteral Feeding of the Critically Ill Patient", Naval Hospital, San Diego, CA. February 1994.
  189. "Nutritional Support of the Critically Ill Patient", Leehigh Valley Hospital, Allentown, PA, February 1994.
  190. "Enteral vs Parenteral Nutritional Support: Selecting Formulas for the Critically Ill", St. Joseph's Medical Center, Doctor's Medical Center and Memorial Hospital Association, Modesto, California, March 1994.
  191. "Enteral Nutritional Support in the Critically Ill", Northern California Society for Parenteral and Enteral Nutrition, Oakland, CA, March 1994.
  192. "Early Enteral Feeding: Who, How, and Why?", Advanced Enteral Feeding for Nutrition Support Practitioners, Sponsored by St. Joseph Hospital, Anaheim, CA, March 1994.
  193. "Electrolyte Disorders", Walter Reed Army Medical Center, Washington, D.C., March 1994.
  194. "Nutritional Immunomodulation", Navy Hospital, Bethesda, MD, March 1994.
  195. "Enteral Nutrition in the Critically Ill", Porta Rico Society for Parenteral and Enteral Nutrition, San Juan, Puerto Rico, March 1994.
  196. "Critical Electrolyte Disturbances" and "Endocrine Emergencies", Current Management in Critical Care, Sponsored by Kansas City Southwest Clinical Society, Kansas City, Kansas, April 1994.
  197. "Magnesium in the Treatment of Burns", Malnutrition in the Hospitalized Patient, Sponsored by Harvard Medical School, Boston, MA, May 1994.
  198. "Point-of-care Testing in the ICU". Medical, Economic, and Regulatory Issues Affecting Point-of-care Testing, Philadelphia, PA, May 1994.
  199. "Surgical nutrition and gut integrity" and "Intact protein, peptide, free amino acid diets: clinical implications", University of New Mexico, Albuquerque, New Mexico, June 1994.
  200. "New research in early enteral feeding: Believe it or not!", and "Electrolyte disorders", Georgia Dietetic Association and Georgia Chapter of the American Society of Parenteral and Enteral Nutrition, Atlanta, Georgia, June 1994.
  201. "Bronchospastic disease", "Sepsis", "Diabetes Mellitus", "Coagulation", "Acute Renal Failure", Nurse Ed Conference, West Palm Beach, Florida, July 1994.
  202. "Requirements for sensor performance for near-patient testing", American Association of Clinical Chemistry, New Orleans, LA, July 1994.
  203. "New ideas for nutrition support of the critically ill patient", Symposium on Nutritional Support of the Critically Ill, Thomason Hospital, El Paso, Texas, August 1994.
  204. "Critical electrolyte disturbances" and "Early aggressive enteral feeding", 9th Annual Pharmacy Practice in Critical Care Medicine, Saint Thomas Hospital, Nashville, Tennessee, Sept 1994.
  205. "New concepts in nutritional support" and "Enteral formula design and managing enteral nutrition support in the ICU patient", Mid-atlantic Society for Parenteral and Enteral Nutrition, Raleigh, NC, Sept 1994.
  206. "Peptide diets" and "Preserving the gut barrier in the critically ill patient", Mexican Association for Enteral and Parenteral Nutrition, Acapulco, Mexico, Sept 1994.
  207. "Critical care nutrition", Northwest Area Health Education Center, Catawba Memorial Hospital, Hickory, Oct 1994.
  208. "Bronchospastic disease", "Sepsis", "Diabetes Mellitus", "Coagulation", "Acute Renal Failure", Nurse Ed Conference, Ashville, NC, Oct 1994.
  209. "Nutrition in the Critically Ill Patient", Carolina Pacific Medical Center, San Francisco, CA, Nov 1994.
  210. "Immunonutrition - Where's the beef?" and "Gastric Tonometry - Does it work?", Controversies in Critical Care, Society of Critical Care Medicine, St. Petersburg, Florida, Dec 1994.
  211. "Study Protocol", Postgraduate course on Research Design, 24th Educational and Scientific Symposium, Society of Critical Care Medicine, San Francisco, CA, Jan 1995.
  212. "Point-of-care testing: The ICU patient laboratory profile", 24th Educational and Scientific Symposium, Society of Critical Care Medicine, San Francisco, CA, Jan 1995.
  213. "Early enteral nutritional support in the critically ill patient", Jefferson Medical College, St. Agnes Medical Center, Lankenau Hospital, Misricordia Hospital, Philadelphia, PA, Feb 1995.
  214. "Immunonutrition in the critically ill patient", Cooper Hospital/University Medical Center, Camden, New Jersey, Feb 1995.
  215. “Advances in Nutritional Support” and “Point of care lab testing”, Butterworth Hospital/Michigan State University, March 1995.
  216. “Nutritional needs of the post-operative patient”, Association of Physician Assistants in Cardiovascular Surgery, Boston, April 1995.
  217. “Benefits of early enteral feeding”, Winston-Salem Dietetic Association, Winston-Salem, April 1995.
  218. “Nutritional support of the critically ill patient”, University of Wisconsin Hospital, Madison, May 1995.
  219. “The critical role of nutrition and immune function in the critically ill and injured”, 8th Annual Trauma Anesthesia and Critical Care Symposium, Baltimore, May 1995
  220. “Nutrition support in critical acre: benefits of early feeding”, Toledo Hospital, Toledo, May 1995.
  221. “Benefits of early feeding”, Erie County Medical Center, Buffalo, June 1995.
  222. “Nutrition and prevention of organ injury- benefits of early enteral feeding”, New Jersey ASPEN, Newark, June 1995.
  223. “Benefits of early enteral feeding”, Reading Hospital, Reading, June 1995.
  224. “Benefits of early nutritional support - prevention of organ injury”, Hershey Medical Center, Hershey, June 1995.
  225. “Benefits of early nutritional support - prevention of organ injury”, Medical Center of Delaware, Wilmington, June 1995.
  226. “Early nutritional support and prevention of organ injury”, Medical College of Pennsylvania, Philadelphia, June 1995.
  227. “Advances in nutritional support: Focus on peptides”, North Carolina Dietetic Association, Greensboro, June 1995.
  228. “Hypertensive emergencies”, “Sedation in the ICU”, “Crystalloids and colloids”, “Use of inotropes”, Components of nutritional formulas”, Nurse Ed, Myrtle Beach, June 1995.
  229. “Hypertensive emergencies”, “Sedation in the ICU”, “Crystalloids and colloids”, “Use of inotropes”, “Components of nutritional formulas”, Nurse Ed, West Palm Beach, July 1995.
  230. “Acid-base disorders”, “Electrolyte Disorders”, “Endocrine Emergencies”, Multidisciplinary Critical Care Review Course, Society of Critical Care Medicine, La Jolla, August 1995.
  231. “Frontiers in Critical Care Nutrition, A specialized approach to the care of the trauma patient”, Memorial Regional Hospital, Hollywood, Florida, and Baptist Hospital, Miami, Florida, September, 1995.
  232. “Role of biogenic amines in nutritional support”, Broward County Quarterly Trauma Meeting, Fort Lauderdale, September 1995.
  233. “Effects of Nutrients on Organ Function”, 10th Annual Clinical Symposium on Nutrition. Mid-atlantic Society for Parenteral and Enteral Nutrition, Winston-Salem, NC, Oct 1995.
  234. “Early enteral nutrition in critically ill patients: why, how and when”, “The role of nutrition in the outcome of critically ill patients: A historical perspective”, “The role of calcium and magnesium in nutritional support”, XI Brazilian Congress of Parenteral and Enteral Nutrition, Caxambu, Brazil, Oct 1995.
  235. “Nutrition in the Immunocompromised Patient”, Annual meeting of the American College of Nutrition, Baltimore, Oct 1995.
  236. “Nutrition in Critical Care”, Sponsored by Area L AHEC, Wilson Memorial Hospital, Wilson, NC, Nov 1995.
  237. “Nutritional Support of the Hospitalized Patient”, Caldwell Memorial Hospital, Lenoir, NC, Nov 1995.
  238. “Hypertensive emergencies”, “Sedation in the ICU”, “Crystalloids and colloids”, “Use of inotropes”, “Components of nutritional formulas”, Nurse Ed, Orlando, Fl, Dec 1995.
  239. “Pathophysiology of Aspiration Pneumonia”, American Society of Parenteral and Enteral Nutrition, Washington, D.C., January 1996.
  240. “Oro- and Nasoenteric Tubes”, Symposium: Overcoming Barriers to Enteral Access in the ICU, The First Annual Meeting on Critical Care Nutrition, Sponsored by Health Communications, New Orleans, Louisiana, Feb 1996.
  241. “Tissue Effects of Biological Amines”, Postgraduate Course on Nutrition, Society of Critical Care Medicine, New Orleans, Louisiana, Feb 1996.
  242. “Basics of Nutritional Support” and “Electrolyte Disorders”, Vail Critical Care Review Course, Vail, Colorado, Feb 1996.
  243. “Early Enteral Nutritional Support”, Charleston-Trident Dietetic Association, Charleston, S.C., Feb 1996.
  244. “Early Enteral Feeding” , Medical University of South Carolina, Charleston, S.C., Feb 1996.
  245. “Enteral versus Parenteral Nutrition: Implications for Organ Function”, Internal Medicine Grand Rounds, Bowman Gray School of Medicine, Winston-Salem, NC, March 1996.
  246. “Early Enteral Nutrition: Effects of Nutrients on Organ Function”, Westchester County Medical Center, New York Medical College, Valhalla, New York, March 1996.
  247. “On the Ropes with Inotropes”, “The Pressure’s On: Treatment of Hypertension”, “Divalent Ions and Cardiac Function”, “Turn Up the Volume: Fluid Resuscitation”, Trends in Cardiovascular Nursing, Washoe Medical Center, Reno, Nevada, March 1996.
  248. “Early enteral nutrition: modulation of organ injury”, Kentucky Society of Parenteral and Enteral Nutrition and University of Kentucky, Lexington, Kentucky, March 1996.
  249. “Effect of nutrient administration on oragn function and outcome”, Surgical Grand Rounds, Dept of Surgery, Bowman Gray School of Medicine, Winston-Salem, NC April 1996.
  250. “Conditional nutrient needs in critical illness”, New Jersey Chapter of the American Society For Parenteral and Enteral Nutrition, College of St. Elizabeth, Morristown, NJ, April 1996.
  251. “Acute Renal Failure in the ICU” and “Acid-Base Disorders”, American College of Physicians, San Francisco, CA, April 1996.
  252. “Methods of Enteral Nutrition in the Critically Ill” and “Calcium/Magnesium”, Nutritional Support of the Hospitalized Patient, Harvard Medical School, Boston, MA, May 1996.
  253. “Nutrition”, Medical and Surgical Grand Rounds, Methodist Hospital, Indianapolis, IN, June 1996.
  254. “Benefits of Early Enteral Feeding”, Phoenix, AZ, July 1996.
  255. “Electrolyte Disorders”, “Endocrine Emergencies”, and “Acid-Base Disorders”, Multidisciplinary Critical Care Review Course sponsored by the Society of Critical Care Medicine, Minneapolis, MN, August 1996.
  256. “The role of magnesium during nutritional support”, “Nutrient modulation of renal injury: prevention of acute renal failure”, “Nutrient modulation of immune function: Can we decrease infections?”, “Early enteral nutrition improves organ function and outcome in critically ill patients”, 9th Argentine Congress of Intensive Care, Buenos Aires, Argentina, August 1996.
  257. “New substrates for the nutritional support of critically ill patients”, “Use of nutritional substrates as pharmacologic agents”, “Nutrition during sepsis”, 23rd National Critical Care Meeting, Veracruz, Mexico, September 1996.
  258. “Determining Method of Nutritional Support: Enteral vs Parenteral”, The Virginia Society for Parenteral and Enteral Nutrition, Roanoke, Virginia, October 1996.
  259. “Perioperative Endocrine Emergencies”, Advances in Physiology and Pharmacology In Anesthesia and Critical Care, White Sulphur Springs, West Virginia, Nov 1996.
  260. “Early Enteral Nutrition”, “Calcium and Magnesium Metabolism During Critical Illness and Septic Shock”, “Endocrine Dysfunction in the ICU”, “Electrolyte Problems: Calcium, and Magnesium Metabolism During Illness”, “Hormones as Therapeutic Agents”, “Catecholamine Action and Resistance”, “Benefits of Early Enteral Nutrition”, University of Hawaii, John A. Burns School of Medicine, Honolulu, Hawaii, Nov 1996.
  261. “Benefits of Early Enteral Nutrition: Improved Outcome”, Cedars Sinai Medical Center & Glendale Adventist Medical Center, Los Angeles, California, January 1997.
  262. “Nutritional Management of the Critically Ill” and “Endocrine Emergencies”, Critical Care Refresher Course, San Diego, California, Feb 1997.
  263. “Nutritional Considerations in the ICU”, “Nutritional Immunomodulation”, “The Gut and Nutrition in Critical Illness”, Annual Meeting of the Society of Critical Care Medicine, San Diego, California, Feb 1997.
  264. “Early Nutritional Support Improves Outcome”, Glendale Memorial Hospital, Glendale, California and Henry Mayo Newhall Memorial Hospital, Valencia, California, Feb 1997.
  265. “Nutritional Support for the Critically Ill Patient”, The Medical Center, Beaver, PA, Feb 1997.
  266. “Early enteral feeding with immune enhancing nutrients improves outcome”, Nutrition Update 1997: Gastrointestinal Diseases, Charlotte Clinic for Gastrointestinal and Liver Diseases and The Charlotte Area Health Education Center, Charlotte, NC, March 1997.
  267. “Benefits of early feeding”, “Nutritional modulation of renal function”, Thyroid alterations during critical illness”, “Magnesium disorders”, 17th International Symposium on Intensive Care and Emergency Medicine, Brussels, Belgium, March 1997.
  268. “Approach to the management of the oliguric patient”, “Electrolyte disorders”, “Endocrine emergencies”, 1st National Convention of Intensive and Critical Care Medicine, Bogota, Colombia, April 1997.
  269. “Enteral versus parenteral nutrition”, LSU Medical School, New Orleans, April 1997.
  270. “Early decisions in nutritional support”, Mercy Hospital, Philadelphia and Pottstown Memorial Hospital, Pottstown, PA, April 1997.
  271. “Immunonutrition”, Allegeny University Hospital, Philadelphia, PA, April 1997.
  272. “Early enteral nutritional support: Benefits of permissive underfeeding”, Conference on Nutritional Support, St. Michael’s Hospital, Toronto, Ontario, May 1997.
  273. “Use of nutrients for prevention of organ injury”, Beth Israel Hospital, Boston, MA, May 1997.
  274. “Early enteral feeding improves outcome in hospitalized patients”, Arizona Dietetic Association Meeting, Litchfield Park, Arizona, June 1997.
  275. “Early Feeding improves outcome in hospitalized patients”, Indian Medical Center and St. Joseph’s Medical Center, Phoenix, Arizona, June 1997.
  276. “Enteral nutrition and prevention of organ injury”, Recent advances in nutritional support, The 7th World Congress of Intensive and Critical Care Medicine, Ottawa, Canada, Junly 1997.
  277. “Alcohol and the GI System”, Symposium on Alcohol and Health, Sponsored by Boston University School of Medicine and The American Wine Alliance for Research and Education (AWARE), Stowe, Vermont, July 1997.
  278. “Immunonutrition” . Westchester Medical Center, New York Medical College and Jacobi Medical Center, Bronx, New York, September 1997.
  279. “Improving Outcomes with Aggressive Nutritional Therapy”, Mercy Hospital, Kern County Medical Center, and Bakersfield Memorial Medical Center, Bakersfield, California, September 1997.
  280. “Inotropes in Septic Shock”, 22nd Australian and New Zealand Scientific Meeting on Intensive Care, Hobart, Tasmania, Australia, October 1997.
  281. “Nutritional Support: Difficulties with Access to the Enteral Route”, “Calcium and Magnesium Metabolism in Critical Illness”, “Early Enteral Feeding and Immune Enhancing Formulas”, 23rd Scientific Meeting of the Australian Society of Parenteral and Enteral Nutrition, Fremantle, Australia, October 1997.
  282. “Enteral Alimentation”, Toronto Critical Care Medicine Symposium, University of Toronto, Toronto, Canada, November 1997.
  283. “Endocrine Emergencies”, “Shock: How are we doing?”, “Inotrope Use In the Critically Ill”, “Crystalloids and Colloids”, “Medical Benefits of Wine”, Nursing Symposium, Nurse Ed, Orlando, Florida, December 1997.
  284. “Biogenic amines and the Immune System”, 22nd Clinical Congress, American Society of Enteral and Parenteral Nutrition, Orlando, Florida, January 1998.
  285. “Inotropic and Vasopressor Agents”, 27th Society of Critical Care Medicine Educational and Scientific Symposium, San Antonio, Texas, February 1998.
  286. “The Nervous System: Catecholamines and Immunoresponse in Septic Shock”, 27th Society of Critical Care Medicine Educational and Scientific Symposium, San Antonio, Texas, February 1998.
  287. “Nutrient Modulation of Organ Injury”, University of Tennessee, Knoxville, TN, February 1998.
  288. “Nutritonal Modulation of Organ Dysfunction” and “Enteral vs Parenteral Nutrition”, Critical Care Medicine Symposium, Institute of Critical Care Medicine, Las Vegas, Nevada, March 1998.
  289. “Biogenic Dietary Peptides: Where are we going?”, Eleventh Annual Nutrition Symposium, Memphis Area Society for Parenteral and Enteral Nutrition and University of Tennessee at Memphis, Memphis, Tennessee, May 1998.
  290. “Endocrine Emergencies” and “Nutritional Prevention of Organ Failure”, Critical Issues in Respiratory and Critical Care Medicine, Staten Island University Hospital Annual Symposium, St. Jean Cap Ferrat, France, June 1998.
  291. “Nutritional Modulation of Organ Function”, Rush-Presby-St. Luke’ s Medical Center, Chicago, Il, July 1998.
  292. “Divalent Ion Concentrations Modulate Outcome During Critical Illness”, Orlando, Florida, October 1998.
  293. “Biological Effects of Food Components: Modulation of Immunity”, Meeting of the American Dietetic Association, Kansas City, Missouri, October 1998.
  294. “Nutritional Prevention of Organ Failure” and “Endocrine Emergencies”, Innovative Approaches to Trauma and Critical Care, New York Medical College, Valhalla, New York, November 1998.
  295. “Early Enteral Nutrition”, Conference on Applied Nutrition in ICU Patients: A Consensus Statement of the American College of Chest Physicians, American College of Chest Physicians, Toronto, Canada, November 1998.
  296. “Enteral Nutrition: Prevention of Organ Failure”, Medicine Grand Rounds, Washington Hospital Center, Washington, DC, December 1998.
  297. “The Interface Between Present and Future Point of Care Testing”, Conference on Point of Care Testing, Society of Critical Care Medicine, San Francisco, California, Jan 1999.
  298. “Enteral Nutrition in the ICU-PRO”, “Enteral Feeding Devices in the Intensive Care Unit”, “Full Nutritional Support in the Critically Ill Patient- CON”, Society of Critical Care Medicine, San Francisco, California, January 1999.
  299. “Enteral Feeding Improves Outcome in Critically Ill Patients”, VA Medical Center Grand Rounds, Washington, DC, January 1999.
  300. “Nutrition and Organ Failure”, Medicine Grand Rounds, National Naval Medical Center, Bethesda, Maryland, February 1999.
  301. “Nutrients & Immune Function”, West Virginia Dietetic Association, Huntington, WV, April, 1999.
  302. “Early Enteral Nutrition”, American Thoracic Society Annual Meeting, San Diego, CA, April 1999.
  303. “Effects of Early Nutrition on Organ Function”, “Lipid intake and gene expression”, “Endocrine emergencies”, New York Critical Care Symposium, New York Medical College, New York, NY, May 1999.
  304. “Lipid intake and gene expression”, Critical Care Grand Rounds, National Institutes of Health, Bethesda, MD, May 1999.
  305. “Specialized nutrition in the ICU”, Current concepts in Critical Care Medicine - 1999, SUNY Health Science Center, Syracuse, NY, June 1999.
  306. Zaloga GP: Early enteral feeding. XXIII National Meeting of the Argentine Society on Intensive Care. Potrero de Los Funes, San Luis, Argentina, September 1999.
  307. Zaloga GP: Enteral Nutrition: New Perspectives.. Argentinean Society of Critical Care Medicine and Argentinean Association of Enteral and Parenteral Nutrition, Buenos Aires, Argentinia, September 1999.
  308. Zaloga GP: Dietary Manipulation of Acute Phase Reactants. New York Academy of the Sciences, New York, New York, September 1999.
  309. Zaloga GP: Early enteral nutrition improves outcome in severely ill patients. Columbia Clinch Valley Medical Center, Richlands, Virginia, September 1999.
  310. Zaloga GP: Nutrition in the ICU: Maintaining Organ Function. Fifth Annual Advances in Pulmonary Medicine, Inova Fairfax Hospital, Fairfax, Virginia, October 1999.
  311. Zaloga GP: “Treatment of Bronchospasm”, Treatment of Intracranial Hypertension”, Divalent Ion Homeostasis”, Intravenous Sedation and Analgesia”, Update in Nutritional Support”, Nurse Ed Conference, Ashville, North Carolina, October 1999.
  312. Zaloga GP: “Point-of-Care Testing: Bedside Technology” & “Enteral vs Parenteral Nutrition”, Toronto Critical Care Medicine Symposium, Toronto, Canada, October 1999.
  313. Zaloga GP: Enteral versus Parenteral Nutrition. Mead Johnson Nutritionals and Northern Virginia Dietetic Association, Chantilly, Virginia, November 1999.
  314. Zaloga GP: Management of Status Epilepticus. Walter Reed Army Medical Center, November 1999.
  315. Zaloga GP: “Adrenal Insufficiency in the ICU: Are We Missing the Diagnosis?”, “Dietary Lipids that Regulate Gene Expression: Implications for Control of the Inflammatory Response”, Critical Care and Emergency Medicine 1999, University of Florida, Orlando, Florida, November 1999.
  316. Zaloga GP: “Lipid intake and control of inflammation”, Medicine Grand Rounds, Washington Hospital Center, Washington, DC, January 2000.
  317. Zaloga GP: Point of Care Diagnostics Braves The Laboratory, Clinical, and Administrative Bermuda Triangle: Cautionary Tales for those Considering Adoption of New Stat Blood Testing Processes: Clinical Perspective. Society of Critical Care Medicine, Orlando, Florida, Feb 2000.
  318. Zaloga GP: Zinc Supplementation: To be or not to be? Society of Critical Care Medicine, Orlando, Florida, Feb 2000.
  319. Zaloga GP: Effects of lipids on gene expression. Society of Critical Care Medicine, Orlando, Florida, Feb 2000.
  320. Zaloga GP: Sedation in the ICU. Fairfax Hospital, Fairfax, Virginia, February 2000.
  321. Zaloga GP: ICU Sedation and Effects on Outcome. Texas Tech University, Lubbock, Texas, March 2000.
  322. Zaloga GP: Nutritional Management in the Critically Ill. American College of Physicians, Philadelphia, PA, April 2000.
  323. Zaloga GP: Adrenal Insufficiency in the Critically Ill Patient. Critical Care Medicine, National Institutes of Health, Bethesda, Maryland, April 2000.
  324. Zaloga GP: Blind Bedside Placement of Enteric Feeding Tubes. Digestive Disease Week, San Diego, California, May 2000.
  325. Zaloga GP: Enteral versus Parenteral Nutrition. Fair Oaks Hospital, Virginia, May 2000.
  326. Zaloga GP: “Review of Propofol: The Triple Drug”. Grand Rounds, Dept of Anesthesiology, Fairfax Hospital, Fairfax, Virginia, August 2000.
  327. Zaloga GP: “Nutritional Support in Hospitalized Patients”, Grand Rounds, Dept of Medicine, Fairfax Hospital, Fairfax, Virginia, September 2000.
  328. Zaloga GP: “Benefits of immunonutrition in the ICU”, “Adrenal Insufficiency in the ICU”, “Physiologic basis of sedation in the ICU”, “Nutrition in the critically ill patient”, 27th National Meeting of the Mexican Association of Critical Care Medicine, Cancun, Mexico, October 2000.
  329. Zaloga GP: Endocrine and Nutrition: Literature Review. American College of Chest Physicians, San Francisco, California, Oct 2000.
  330. Zaloga GP: Micronutrient Supplementation. Emory University, Atlanta, Georgia, January 2001.
  331. Zaloga GP: Improving Outcome with Nutritional Support, Select Medical Meeting, Orlando, Florida, Feb 2001.
  332. Zaloga GP: “Endocrine Dysfunction Syndromes During Critical Illness”, Critical Care Refresher Course, Society of Critical Care Medicine, San Francisco, California, Feb 2001.
  333. Zaloga GP: “Calcium Homeostasis in the Critically Ill”, “Trace Metal Chelation with EDTA in the Critically Ill”, “Aggressive Caloric Support is not Necessary for Optimal Benefits”, 30th International Educational and Scientific Symposium, Society of Critical Care Medicine, San Francisco, California, Feb 2001.
  334. Zaloga GP: Improving Outcome with Nutritional Support, Surgical Grand Rounds, Georgetown University Medical Center, Washington, DC, Feb 2001.
  335. ZalogaGP: Enteral versus Parenteral Nutrition. Virginia Dietetic Association Meeting, Fairfax, VA, March 2001.
  336. Zaloga GP: “Nutritional Support of the Critically Ill Patient” and “Endocrine Emergencies”, American College of Physicians Meeting, Critical Care Medicine Course, Atlanta, Georgia, March 2001.
  337. Zaloga GP: Improving Outcome with Nutritional Support, Kaiser, Oakland, CA, April 2001.
  338. Zaloga GP: Improving Outcome in Hospitalized Patients with Early Nutritional Support, Grand Rounds, Suburban Hospital, Bethesda, MD, May 2001.
  339. Zaloga GP: A Clinicians Perspective of Point-of-care Testing: Present Clinical Issues and Future Needs. Congress on Clinical Chemistry, Prague, Czech Republic, May 2001.
  340. Zaloga GP: Critical Care Nutrition – Present Status and Future Perspectives. 38th Annual Meeting of the Japanese Society for Surgical Metabolism and Nutrition, Chiba City, Japan, July 2001.
  341. Zaloga GP: Immunonutrition. Toronto Critical Care Symposium, Toronto, Canada, Oct 2001.
  342. Zaloga GP: Critical Care Literature Review: Nutrition, Gastroenterology, Endocrine and Metabolic issues. American College of Chest Physicians, Philadelphia, PA, November 2001.
  343. Zaloga GP: Endocrine Emergencies. Sixth Critical Care Refresher Course, Society of Critical Care Medicine, San Diego, California, January 2002.
  344. Zaloga GP: “Nutrition Goals for Optimum Outcome: Is this a good time for a diet?”, Multidisciplinary management of the Morbidly Obese Patient, Society of Critical Care Medicine, San Diego, California, January 2002.
  345. Zaloga GP: To feed or not to feed – Is that the question? Meet the Professor, Society of Critical Care Medicine, San Diego, California, January 2002.
  346. Zaloga GP: Improving outcome with Nutrition Support in Critically Ill Patients, Loyola, Maywood, IL, January 2002.
  347. Zaloga GP: Improving outcome with Nutrition Support, Eastern Maine Medical Center, Bangor Maine, February 2002.
  348. Zaloga GP: Aspiration Related Illnesses. North American Summit on Aspiration, San Francisco, May 2002.
  349. Zaloga GP: Nutritional Needs of the Critical Care Patient. Topics in Critical Care: Issue and Strategies, Clarian Health, Indianapolis, IN, Sept 2002.
  350. Zaloga GP: Early enteral feeding. KYSPEN/ISPEN 2002: Clinical Nutrition Update, Louisville, KY, October 2002
  351. Zaloga GP: Critical Care Medicine Literature Review – Nutrition, Metabolism, Endocrine, Gastroenterology. American College of Chest Physicians, San Diego, CA, November 2002.
  352. Zaloga GP: Nutritional support of the acute care patient. St. Luke’s Hospital, Bethleham, PA, January 2003.
  353. Zaloga GP: “Aspiration: Diagnosis,terminology, epidemiology”, “Impact of enteral feeding on the patient”, “Controversies in Immunonutrition”, Nutrition Week, San Antonio, Texas, January 2003.

Panels

  1. Does Parenteral Nutrition Save or Risk Lives During the Acute Phase of Critical Illness? Critical Care Medicine 23rd Annual Symposium, Las Vegas, NV, February 1985.
  2. Future Directions in Critical Care. Thirty-Seventh Annual Postgraduate Program, Critical Care Medicine, Roanoke Memorial Hospitals, Roanoke, VA, March 1986.
  3. Chairman, Critical Care and Psychiatry Interface Panel. Society of Critical Care Medicine Annual Scientific and Educational Symposium, Washington, DC, May 1986.
  4. Chairman, Panel on Pancreatitis. Society of Critical Care Medicine Annual Scientific and Educational Symposium, Washington, DC, May 1986.
  5. Special Nutritional Problems in the ICU. Society of Critical Care Medicine Annual Scientific and Educational Symposium, Washington, DC, May 1986.
  6. The First Consensus Development Conference on the Treatment of Radiation Injuries, Washington, DC, May 1989.
  7. Early Enteral vs. Parenteral Nutrition in Sepsis and Trauma. M.A.S.P.E.N., Charlotte, NC, October, 1989.
  8. Chairman, Consensus conference on enteral feeding, Hilton Head, SC, June 1991.
  9. Glucagon - Its Use in Emergency Medicine, International Symposium, Barcelona, Spain, Oct 1992.
  10. Consensus Conference on Nutritional Support of the Critically Ill Patient, American College of Chest Physicians, Chicago, IL, Dec 1993.
  11. Medical Aspects of Point-of-care Testing, Medical, Economic, and Regulatory Issues Affecting Point-of-care Testing, Philadelphia, PA, May 1994.
  12. Nutritional Support in Acute Pancreatitis and Consensus in Nutritional Assessment. XI Brazilian Congress of Parenteral and Enteral Nutrition, Caxambu, Brazil, Oct 1995.
  13. Common day problems in feeding the critically ill patient, 9th Argentine Congress of Critical Care, Buenos Aires, Argentina, August 1996.
  14. Consensus conference on bedside laboratory testing in critical care, Sponsored by the American College of Chest Physicians, Cape Cod, MA, Sept 1996.
  15. Nutritional Support, 17th International Symposium on Intensive Care and Emergency Medicine, Brussels, Belgium, March 1997.
  16. Metabolic and gastrointestinal disorders, 1st National Convention of Intensive and Critical Care Medicine, Bogota, Colombia, April 1997.
  17. Early enteral feeding - Fact of fad?, The 7th World Congress of Intensive and Critical Care Medicine, Ottawa, Canada, July 1997.
  18. Nutritional Management - Case Presentation, 23rd Scientific Meeting of the Australian Society of Parenteral and Enteral Nutrition, Fremantle, Australia, October 1997.
  19. Coagulation Testing In Critical Care Medicine, Sponsored by Hewlett-Packard, Baltimore, Maryland, February 1998.
  20. The Critically Ill Patient: Gut, blood flow, mucosal permeability, and tropism. XXIII National Meeting of the Argentine Society on Intensive Care, Portero de los Funes, San Luis, Argentina, September 1999.
  21. Nutritional Support of the Critically Ill Patient: An evidenced based approach. Toronto, Canada, Oct 2001.
  22. North American Summit on Aspiration. San Francisco, California, May 2002.
  23. Nutrition in the Critically Ill Patient, Dallas, Texas, June 2002
  24. Controvesies in Immunonutrition, Nutrition Week, San Antonio, Texas, January 2003.

BIBLIOGRAPHY:

Monographs And Textbooks:

  1. Chernow B, Zaloga GP, eds. Hormonal and metabolic considerations. Gaithersburg, MD: Aspen Systems, 1983. (Critical Care Quarterly; v.6)
  2. Chernow B, Zaloga GP, eds. Endocrine aspects of critical illness. New York: Thieme-Stratton, 1985. (Seminars in Respiratory Medicine; v.7)
  3. Chernow B ed. Holaday JW, Zaloga GP, Zaritsky AL, assoc. eds. The pharmacologic approach to the critically ill patient, 2nd ed. Baltimore: Williams & Wilkins, 1988.
  4. Chernow B, Holaday JW, Zaloga GP, Zaritsky AL. Essentials of critical care pharmacology. Baltimore: Williams & Wilkins, 1989.
  5. Zaloga GP. Endocrine Emergencies. Problems in Critical Care, Philadelphia: J.B. Lippincott, 1990; 4, No 3.
  6. Zaloga GP. Endocrine Crisis. Critical Care Clinics, Philadelphia: W.B. Saunders, 1991, vol 7, No. 1.
  7. Zaloga GP. The Critical Care Drug Handbook. Mosby-Year Book, St. Louis, 1991.
  8. Chernow B ed. Holaday JW, Zaloga GP, Zaritsky AL, assoc. eds. The pharmacologic approach to the critically ill patient, 3rd ed. Baltimore: Williams & Wilkins, Baltimore, 1994.
  9. Zaloga GP. Nutrition in Critical Care. Mosby-Year Book, St. Louis, 1994.
  10. Zaloga GP. Frontiers in Critical Care Nutrition. New Horizons 1994, Volume 2, Number 2.
  11. Zaloga, GP, MacGregor D: The Critical Care Drug Handbook, Ed 2, Mosby-Year Book, St. Louis, 1997.
  12. Zaloga GP, Zimmerman JL: Multidisciplinary Critical Care Board Review Course Syllabus. Society of Critical Care Medicine, Anaheim, California, 1996.
  13. Zaloga GP: Section Editor, “Endocrinology, Metabolism, Nutrition, Pharmacology”, Textbook of Critical Care, Grenvik A, Ayres SM, Holbrook PR, Shoemaker WC (eds), 4th ed. WB Saunders, Philadelphia, 2000.
  14. Zaloga, GP, Matuschak G: The Safety and Efficacy of Propofol Containing EDTA: A randomized clinical trial programme focusing on cation and trace metal homeostasis in critically ill patients. Intensive Care Medicine (Supplement) 2000; 26: S397-462.
  15. Zaloga GP, Marik P: Endocrine and Metabolic Dysfunction Syndromes in the Critically Ill, Critical Care Clinics 2001; 17: 1-252.
  16. Siddiqui R, Zaloga GP: Biologic Mechanisms of Macronutrient Action, in preparation.

Chapters in Books:

  1. Zaloga GP, Chernow B. Calcium, magnesium and other minerals. In: Chernow B, Lake CR, eds. The Pharmacologic Approach to the Critically Ill Patient. Baltimore: Williams & Wilkins, 1983:530-561.
  2. Zaloga GP, Chernow B. Insulin, glucagon and growth hormone. In: Chernow B, Lake CR, eds. The Pharmacologic Approach to the Critically Ill Patient. Baltimore: Williams & Wilkins, 1983:562-585.
  3. Zaloga GP, Chernow B. Thyroid function in acute illness. In: Geelhoed GW, Chernow B, eds. Endocrine Aspects of Acute Illness. New York: Churchill Livingston, 1985:67-96. (Clinics in Critical Care Medicine; v.5)
  4. Zaloga GP, Chernow B. Calcium metabolism. In: Geelhoed GW, Chernow B, eds. Endocrine Aspects of Acute Illness. New York: Churchill Livingston, 1985:169-204. (Clinics in Critical Care Medicine; v.5)
  5. Chester WL, Zaloga GP, Chernow B. Phosphate problems in the critically ill patient. In: Geelhoed GW, Chernow B, eds. Endocrine Aspects of Acute Illness. New York: Churchill Livingston, 1985:205-216. (Clinics in Critical Care Medicine; v.5)
  6. Zaloga GP, Chernow B. Life-threatening electrolyte and metabolic abnormalities. In: Parrillo JE, ed. Current Therapy in Critical Care Medicine. Toronto: Decker, 1987:245-257.
  7. Zaloga GP, Chernow B. Diabetes and diabetic coma. In: Parrillo JE, ed. Current Therapy in Critical Care Medicine. Toronto: Decker, 1987:297-299.
  8. Zaloga GP, Chernow B. Addisonian crisis, hyperthyroidism, and hypothyroidism. In: Parrillo JE, ed. Current Therapy in Critical Care Medicine. Toronto: Decker, 1987:300-305.
  9. Zaloga GP, Chernow B. Endocrine and metabolic problems in the critically ill immunocompromised patient. In: Parrillo JE, Masur H, eds. The Critically Ill Immunosuppressed Patient: Diagnosis and Management. Rockville, MD: Aspen, 1987:155-188.
  10. Zaloga GP. Hyperosmolar states. In: Civetta JM, Taylor RW, Kirby RR, eds. Critical Care. Philadelphia: J.B. Lippincott, 1988:475-482.
  11. Malcolm D, Holaday JW, Chernow B, Zaloga GP. Calcium and calcium antagonists in shock and ischemia. In: Chernow B, ed. The Pharmacologic Approach to the Critically Ill Patient, 2nd ed. Baltimore: Williams & Wilkins, 1988:889-900.
  12. Zaloga GP, Chernow B. Divalent ions: calcium, magnesium, and phosphorus. In: Chernow B, ed. The Pharmacologic Approach to the Critically Ill Patient, 2nd ed. Baltimore: William & Wilkins, 1988:603-636.
  13. Zaloga GP, Chernow B. Part 1: Insulin and oral hypoglycemics. In: Chernow B, ed. The Pharmacologic Approach to the Critically Ill Patient, 2nd ed. Baltimore: Williams & Wilkins, 1988:637-658.
  14. Zaloga GP, Malcolm DS, Holaday JW, Chernow B. Part 2: Glucagon. In: Chernow B, ed. The Pharmacologic Approach to the Critically Ill Patient, 2nd ed. Baltimore: Williams & Wilkins, 1988:659-670.
  15. Chernow B, Wiley SC, Zaloga GP. Critical care endocrinology. In: Shoemaker WC, Ayres S, Grenvik A, Holbrook PR, Thompson WL, eds. Textbook of Critical Care. Philadelphia: W.B. Saunders, 1989:736-766.
  16. Zaloga GP, Eil C. Diseases of the parathyroid glands and nephrolithiasis during pregnancy. In: Brody SA, Ueland K, eds. Endocrine Disorders in Pregnancy. Appleton & Lange, Norwalk, 1989:231-246.
  17. Zaloga GP (Contributor). Endocrinology. In: Sahn SA, Heffner JE, eds. Critical Care Pearls. Philadelphia: Hanley and Belfus, 1989:217-236.
  18. Zaloga GP, Chernow B. Divalent ions: calcium, magnesium and phosphorus. In: Chernow B, et al, eds. Essentials of Critical Care Pharmacology. Baltimore: Williams & Wilkins, 1989:348-381.
  19. Zaloga GP. Prevention of infection with endogenous organisms. In: Browne D, et al, eds. Treatment of Radiation Injuries. New York: Plenum Publishing Company, 1990:115-126.
  20. Zaloga GP. Calcium disorders. In: Zaloga GP, ed. Endocrine Emergencies, Problems in Critical Care, 1990;4:382-401.
  21. Zaloga GP. Phosphate disorders. In: Zaloga GP, ed. Endocrine Emergencies, Problems in Critical Care 1990;4:416-424.
  22. Zaloga GP, Roberts JE. Magnesium disorders. In: Zaloga GP, ed. Endocrine emergencies, Problems in Critical Care 1990;4:425-436.
  23. Butterworth J, Strickland R, Zaloga GP. Hemodynamic actions and drug interactions of calcium and magnesium. In: Zaloga GP, ed. Endocrine Emergencies, Problems in Critical Care 1990;4:402-415.
  24. Prielipp R, Zaloga GP. Calcium action and General Anesthesia. Advances in Anesthesia 1991;8:241-278.
  25. Zaloga GP. Hypocalcemic crisis. In: Zaloga GP, ed. Endocrine Crisis, Critical Care Clinics 1991;7:191-200.
  26. Zaloga GP. Nutrition and prevention of systemic infection. Critical Care-State of the Art 1991;12:31-79.
  27. Prough DS, Zaloga GP. Hypovolemia and renal dysfunction. In: Benumof JL, Saidman LJ, eds. Anesthesia and Perioperative Complications. St. Louis: Mosby-Year Book, 1992:434-465.
  28. Zaloga GP. Calcium homeostasis during sepsis. In: Vincent JL, ed. Yearbook on Intensive Care and Emergency Medicine. Berlin: Springer-Verlag 1992:620-631.
  29. Zaloga GP. Hyperosmolality. In: Civetta JM, Taylor RW, Kirby RR, eds. Critical Care. Philadelphia: J.B. Lippincott, 1992:447-456.
  30. Zaloga GP. Electrolyte disorders. In: Civetta JM, Taylor RW, Kirby RR, eds. Critical Care. Philadelphia: J.B. Lippincott, 1992:481-505.
  31. Zaloga GP, Prough DS. Fluids and electrolytes. In: Barash PG, Cullen BF, Stoelting RK, eds. Clinical Anesthesia, 2nd ed, Philadelphia: J.B. Lippincott, 1992:203-236.
  32. Zaloga GP. Studies comparing intact protein, peptide, and amino acid formulas. In: Bounous G, ed. Uses of Elemental Diets in Clinical Situations. CRC Press, Boca Raton, 1993, 201-217.
  33. Zaloga GP, Prough DS (contributors). Fluids and electrolytes. In: Barash PG, Cullen BF, Stoelting RK, eds. Handbook of Clinical Anesthesia, 2nd ed, J.B. Lippincott Company, Philadelphia, 1993, 89-104.
  34. Zaloga GP. Calcium, Catecholamine Action, and Cardiovascular Function During Critical Illness. In Vincent JL (ed), Yearbook of Intensive Care and Emergency Medicine, Springer-Verlag, Berlin, 1993, 340-353.
  35. Zaloga GP, Prielipp RC, Butterworth JF, Royster RL. Pharmacologic Cardiovascular Support. Critical Care Clinics 1993; 9: 335-362.
  36. Zaloga GP, Malcolm D. Calcium as a mediator in septic shock. In: Neugebauer E, Holaday J, eds. Handbook of Mediators in Septic Shock. CRC Press, Inc., Boca Raton, Florida, 1993, 475-485.
  37. Zaloga GP. Cardiovascular Emergencies. In Picazo J (ed), Glucagon in Acute Medicine, Kluwer Academic Publishers, Boston, 1993, 11-23.
  38. Zaloga GP. Parenteral versus Enteral Nutrition. In Wilmore DW, Carpentier YA (eds), Metabolic Support of the Critically Ill Patient, Springer-Verlag, Berlin, 1993, 267-293.
  39. Zaloga GP, Bortenschlager L: Vitamins. In Zaloga GP (ed), Nutrition in Critical Care, Mosby-Year Book, St. Louis, 1994, 217-242.
  40. Zaloga GP: Timing and route of nutritional support. In Zaloga GP (ed), Nutrition in Critical Care, Mosby-Year Book, St. Louis, 1994, 297-330.
  41. Zaloga GP: Intact protein, peptide and amino acid formulas. In Zaloga GP (ed), Nutrition in Critical Care, Mosby-Year Book, St. Louis, 1994, 59-80.
  42. Suleiman M, Zaloga GP: Nutrition in acute renal failure. In Zaloga GP (ed), Nutrition in Critical Care, Mosby-Year Book, St. Louis, 1994, 661-684.
  43. Zaloga GP, Chernow B. Divalent ions: calcium, magnesium, and phosphorus. In: Chernow B, ed. The Pharmacologic Approach to the Critically Ill Patient. Baltimore: Williams & Wilkins, 1994, 777-804.
  44. Zaloga GP, Chernow B. Insulin and oral hypoglycemics. In: Chernow B, ed. The Pharmacologic Approach to the Critically Ill Patient. Baltimore: Williams & Wilkins, 1994, 758-776.
  45. Bortenschlager B, Zaloga GP. Vitamins. In: Chernow B, ed. The Pharmacologic Approach to the Critically Ill Patient. Baltimore: Williams & Wilkins, 1994, 805-819.
  46. Zaloga GP. Hormones: vasopressin, growth hormone, glucagon, somatostatin, prolactin, G-CSF, GM-CSF. In: Chernow B, ed. The Pharmacologic Approach to the Critically Ill Patient. Baltimore: Williams & Wilkins, 1994, 700-714.
  47. Zaloga GP. Enteral nutrition. In: Chernow B, ed. The Pharmacologic Approach to the Critically Ill Patient. Baltimore: Williams & Wilkins, 1994, 1034-1050.
  48. Zaloga GP, Ober KP, Cefalu WT. Endocrinology consultation. In: Kirby RR, Gravenstein N, eds. Manual of Clinical Anesthesia Practice. Philadelphia: W.B. Saunders, 1994, 185-210.
  49. Butterworth JF, Zaloga GP: Calcium and Magnesium as Vasoactive Drugs. In Skarvan K (ed), Vasoactive Drugs, Baillere's Clinical Anesthesiology, Bailliere Tindall, London, 1994; 8: 109-136.
  50. Johnson MJ, Zaloga GP: The place of glucagon in emergency medicine, In Lefebvre P (ed), Glucagon III, Springer Verlag, Berlin, 1996, 171-193.
  51. Zaloga GP, Kirby RR, Bernards WC, Layon AJ: Fluid and Electrolytes. In Civetta JM, Taylor RW, Kirby RR (eds), Critical Care, 3rd ed, Lippincott-Raven, Philadelphia, 1997, 413-441.
  52. Butterworth JF, Prielipp R, MacGregor D, Zaloga GP: Pharmacologic cardiovascular support. In Kvetan V, Dantzker D (eds), The critically ill cardiac patient: Multisystem dysfunction and magangement, JB Lippincott, Philadelphia, 1996, 167-192.
  53. Zaloga GP, Roberts PR: Early enteral feeding improves outcome. Yearbook of Intensive Care and Emergency Medicine, Springer-Verlag, Berlin, 1997, 701-714.
  54. Contributer, Critical Care Pearls, Sahn SA and Heffner JE (eds), 2nd ed, Hanley and Belfus, Philadelphia, 1998.
  55. Zaloga GP: On-line monitoring of Glucose and Electrolytes. In Tobin MJ (ed), Principles and Practice of Intensive Care Monitoring, McGraw-Hill, New York, 1998, 1125-1132.
  56. Contributor: The A.S.P.E.N. Nutrition Support Practice Manual, American Society of Parenteral and Enteral Nutrition, Silver Spring, Maryland, 1998.
  57. Lee E, Zaloga GP: Neuroendocrine Immunology. In Grenvik A, Ayres SM, Holbrook PR, Shoemaker WC (eds), Textbook of Critical Care, 4th ed, WB Saunders, Philadelphia, 2000, pgs 821-828.
  58. Zaloga GP, Roberts PR: Calcium, Phosphorus, and Magnesium Disorders. In Grenvik A, Ayres SM, Holbrook PR, Shoemaker WC (eds), Textbook of Critical Care, 4th ed, WB Saunders, Philadelphia, 2000, pgs 862-875.
  59. Roberts PR, Zaloga GP: Enteral Nutrition in the Critically Ill Patient. In Grenvik A, Ayres SM, Holbrook PR, Shoemaker WC (eds), Textbook of Critical Care, 4th ed, WB Saunders, Philadelphia, 2000, pgs 875-898.
  60. Zaloga GP, Bortenschlager L: Morbid Obesity in Critical Illness. In Grenvik A, Ayres SM, Holbrook PR, Shoemaker WC (eds), Textbook of Critical Care, 4th ed, WB Saunders, Philadelphia, 2000, pgs 950-961.
  61. Zaloga GP, Marik P: Hypothalamic-Pituitary-Adrenal Insufficiency. Crit Care Clinics 2001: 17: 25-41.
  62. Zaloga GP, Marik P: Lipid Modulation and Systemic Inflammation. Crit Care Clinics 2001: 17: 201-217.
  63. Zaloga GP, Bhatt B, Marik P: Systemic inflammation and neuroendocrine function. In Becker KL, Nylen ES (eds), Principles and practice of endocrinology and metabolism, 3rd ed, Lippincott/Williams and Wilkins, Philadelphia, 2001, pgs 2068-2076.
  64. Nylen E, Zaloga G, Burman K et al: Current and potential endocrine therapeutics in critical illness. In Becker KL, Nylen ES (eds), Principles and practice of endocrinology and metabolism, 3rd ed, Lippincott/Williams and Wilkins, Philadelphia, 2001, pgs 2108-2121.
  65. Zaloga GP, Marik P: Adrenal Insufficiency. O’DonnelJM, et al (eds), Surgical Intensive Care Medicine Handbook, Kluwer Academic Publishers, Norwell, Massachusetts, In press.
  66. Zaloga GP: Care of the Patient with Endocrine Emergencies. In Murray, Coursin, Pearl, Prough (eds), Critical Care Medicine: Perioperative Management, edition 2, Lippincott Williams & Wilkins, New York, In press.

Journal Articles:

  1. Zaloga G, Sarma R. New method for extending the diffraction pattern from protein crystals and preventing their radiation damage. Nature 1974;251:551-552.
  2. Sarma R, Zaloga G. Structure studies on styrene-treated immunoglobulin crystals. J Mol Biol 1975;98:479-484.
  3. Zaloga GP. Asbestos related diseases: a review. Milit Med 1981;146:413-415,419.
  4. Zaloga GP, Chernow B, Clapper M, Dudley AH. Neuroarthropathy in diabetes mellitus. J Fam Pract 1982;14:775-776,778.
  5. Zaloga GP, Chernow B, Lake CR. Nitroglycerin use in the critically ill patient. IM Intern Med Spec 1982 Jun;3:98-99,102-106.
  6. Zaloga GP, Chernow B. Life-threatening anaphylactic reaction to tetanus toxoid. Ann Allergy 1982;49:107-108.
  7. Chernow B, Zaloga G, McFadden E, Clapper M, Kotler M, Barton M, Rainey TG. Hypocalcemia in critically ill patients. Crit Care Med 1982;10:848-851.
  8. Chernow B, Lake CR, Zaloga GP, Coleman MD, Ziegler MG. Effect of clonidine on sympathetic nervous system activity in patients with essential hypertension. Int J Clin Pharmacol Res 1983;3:9-15.
  9. Zaloga GP, Chernow B, Chin R, Deal J, Robinson A, Barber B, Kaminsky HH. Gastroesophageal fundoplication improves symptoms in refractory asthma. Am Surg 1983;49:403-404.
  10. Zaloga GP, Hughes P, Cohen D, Chernow B, Rainey TG, Lake CR. Differential hemodynamic response to vasodilators in a patient with pulmonary hypertension: a case report. Milit Med 1983;148:426-429.
  11. Spurling TJ, Zaloga GP, Richter JE. Fiberendoscopic removal of a gastric foreign body with overtube technique. Gastrointest Endosc 1983;29:226-227.
  12. McFadden EA, Zaloga GP, Chernow B. Hypocalcemia: a medical emergency. Am J Nurs 1983 Feb;83:227-230.
  13. Zaloga GP, Chernow B. Postprandial hypoglycemia after Nissen fundoplication for reflux esophagitis. Gastroenterology 1983;84:840-842.
  14. Zaloga GP, Pilley MP, Chernow B, Rainey TG, Hughes P, Lake CR. Effective use of vasodilators in pulmonary hypertension secondary to recurrent thromboembolic disease. US Navy Med 1983 Jan-Feb;74:33-35.
  15. Zaloga GP, Chernow B, Holt MR, Hughes P, Pilley MP, Rainey TG, Lake CR. Effect of vasodilators on pulmonary vascular resistance in patients with pulmonary hypertension. Clin Pharm 1983;2:265-268.
  16. Finton CK, Bjorkland S, Zaloga GP, Uddin DE, Chernow B. Gentamicin-induced hypomagnesemia. Am Surg 1983;49:576-578.
  17. McFadden EA, Zaloga GP. Calcium regulation. Crit Care Q 1983 Dec;6:12-21.
  18. Zaloga GP, Chernow B. Hypocalcemia: direct measurement of ionized calcium gives the truest picture. Crit Care Monit 1983;3:1,10-11.
  19. Zaloga GP, Chernow B. Magnesium metabolism in critical illness. Crit Care Q 1983 Dec;6:22-27.
  20. Zaloga GP, Chernow B. Hormones as therapeutic agents in the intensive care unit. Crit Care Q 1983 Dec;6:75?85.
  21. Chernow B, Zaloga GP, Lake CR, Coleman MD, Ziegler MG. Effect of antihypertension therapy on sympathetic nervous system activity in patients with essential hypertension. Fed Proc 1984;43:72-77.
  22. Zaloga GP, Hostinsky C, Chernow B. Endogenous opioid peptides: critical care implications. Heart Lung 1984;13:421-430.
  23. Chernow B, Lake CR, Barton M, Chobanian S, Zaloga GP, Casey LE, Flethcer JR. Sympathetic nervous system sensitivity to hemorrhagic hypotension in the subhuman primate. J Trauma 1984;24:229-232.
  24. Zaloga GP, Chernow B, Pock A, Wood B, Zaritsky A, Zucker A. Hypomagnesemia is a common complication of aminoglycoside therapy. Surg Gynecol Obstet 1984;158:561-565.
  25. Zaloga GP, Chernow B, Zajtchuk R, Chin R, Rainey TG, Lake CR. Diagnostic dosages of protirelin (TRH) elevate blood pressure by noncatecholamine mechanisms. Arch Intern Med 1984;144:1149-1152.
  26. Zaloga GP, Chernow B, Fletcher JR, Hughes P, Rainey TG, Lake CR. Increased circulating plasma norepinephrine concentrations in noncardiac causes of pulmonary hypertension. Crit Care Med 1984;12:85-89.
  27. Chernow B, Zaloga GP, Soldano S, Quinn T, Lyons P, McFadden E, Cook D, Rainey TG. Measurement of urinary leukocyte esterase activity: a screening test for urinary tract infections. Ann Emerg Med 1984;13:150-154.
  28. Zaloga GP, Chernow B, McFadden E, Soldano S, Lyons P, O'Brian JT. Urine glucose testing in the critically ill: a comparison of two enzymatic test strips. Crit Care Med 1984;12:188-190.
  29. Hall-Boyer K, Zaloga GP, Chernow B. Glucagon: hormone or therapeutic agent? Crit Care Med 1984;12:584-589.
  30. Chernow B, Vernoski BK, Zaloga GP, Cook D, D'Angona D Jr, Van Ness M, Casey LC, Fletcher JR. Dexamethasone causes less steroid-induced alkalemia than methylprednisolone or hydrocortisone. Crit Care Med 1984;12:384-386.
  31. Zaloga GP, Hierlwimmer UR, Engler RJ. Anaphylaxis following psyllium ingestion. J Allergy Clin Immunol 1984;74:79-80.
  32. Zaloga GP, Eil C, O'Brian JT. Reversible hypocalciuric hypercalcemia associated with hypothyroidism. Am J Med 1984;77:1101-1104.
  33. Zaloga GP, Dons RF. Exercise-induced hypoglycemia following propranolol in a patient after gastric fundoplication surgery. Dig Dis Sci 1984;29:1164-1166.
  34. Chernow B, Zaloga GP. SCCM - ions for Society members: sulfate, chloride, calcium and magnesium. Crit Care 1984;5:V(K)1-V(K)43.
  35. Zaloga GP, Chernow B. The use of hormones as therapeutic agents. Semin Respir Med 1985;7:39-51.
  36. Zaloga GP, Chernow B. Stress-induced changes in calcium metabolism. Semin Respir Med 1985;7:52-68.
  37. Zaloga GP, O'Brian JT. Euthyroid sick syndrome. Am Fam Physician 1985 Feb;31:236-250.
  38. Zaloga GP, Eil C, Medbery CA. Humoral hypercalcemia in Hodgkin's disease associated with elevated 1,25?dihydroxycholecalciferol levels and subperiosteal bone resorption. Arch Intern Med 1985;145:155-157.
  39. Lee C, Zaloga GP. Magnesium metabolism. Semin Respir Med 1985;7:75-80.
  40. Zaloga GP, Smallridge RC. Thyroidal alterations in acute illness. Semin Respir Med 1985;7:95-107.
  41. Zaloga GP, Chernow B, Smallridge RC, Zajtchuk R, Hall-Boyer K, Hargraves R, Lake CR, Burman KD. A longitudinal evaluation of thyroid function in critically ill surgical patients. Ann Surg 1985;201:456-464.
  42. Zaloga GP, Chernow B, Eil C. Hypercalcemia and disseminated cytomegalovirus infection in the acquired immunodeficiency syndrome. Ann Intern Med 1985;102:331-333.
  43. Barber WB, Smith LE, Zaloga GP, Fletcher JR, Cook D, Lake CR, Chernow B. Hemodynamic and plasma catecholamine responses to epinephrine-containing perianal lidocaine anesthesia. Anesth Analg 1985;64:924-928.
  44. Zaloga GP, Deal J, Spurling T, Richter J, Chernow B. Case report: unusual manifestations of arsenic intoxication. Am J Med Sci 1985;289:210-214.
  45. Smallridge RC, Chernow B, Snyder R, Zaloga GP, Burman KD. Angiotensin-converting enzyme activity: a potential marker of tissue hypothyroidism in critical illness. Arch Intern Med 1985;145:1829-1832.
  46. Zaloga GP, Chernow B, Cook D, Snyder R, Clapper M, O'Brian JT. Assessment of calcium homeostasis in the critically ill surgical patient: the diagnostic pitfalls of the McLean-Hastings nomogram. Ann Surg 1985;202:587-594.
  47. Zaloga GP, Cook D, Finton C, Dons R. Hyperthyroidism following surgical stress in previously euthyroid patients. Milit Med 1986;151:169-172.
  48. Zaloga GP, Rainey TG. Hypocalcemia in the critically ill: when to suspect and what to do. J Crit Illness 1986 Apr;1:12-16,21-23.
  49. Zaloga GP, DeLacey W, Holmboe E, Chernow B. Glucagon reversal of hypotension in a case of anaphylactoid shock. Ann Intern Med 1986;105:65-66.
  50. Malcolm D, Zaloga GP, Chernow B, Holaday JW. Glucagon is an antagonist of morphine bradycardia and antinociception. Life Sci 1986;39:399-405.
  51. Meyers A, Zaloga GP. Malnutrition in hospitalized patients: recognition and initial management. US Navy Med 1986 Jul/Aug;77:3-7.
  52. Zaloga GP, Chernow B. Hypocalcemia in critical illness. JAMA 1986;256:1924-1929.
  53. Zaloga GP, Malcolm D, Holaday J, Chernow B. Verapamil reverses calcium cardiotoxicity. Ann Emerg Med 1987;16:637-639.
  54. Chernow B, Zaloga GP, Malcolm D, Willey SC, Clapper M, Holaday JW. Glucagon's chronotropic action is calcium dependent. J Pharmacol Exp Ther 1987;241:833-837.
  55. Zaloga GP, Willey S, Tomasic P, Chernow B. Free fatty acids alter calcium binding: a cause for misinterpretation of serum calcium values and hypocalcemia in critical illness. J Clin Endocrinol Metab 1987;64:1010-1014.
  56. Zaloga GP, Chernow B. The multifactorial basis for hypocalcemia during sepsis: studies of the parathyroid hormone-vitamin D axis. Ann Intern Med 1987;107:36-41.
  57. Chernow B, Zaloga GP. Pharmacologic management of the critically ill patient in the perioperative period: emphasis on the sepsis syndrome. Med Clin North Am 1987;71:541-549.
  58. Zaloga GP, Chernow B, Hodge J, Eil C. Hypocalcemia and altered vitamin D metabolism in patients with small intestinal disease. Milit Med 1988;153:34-37.
  59. Zaloga GP, Wilkins R, Tourville J, Wood D, Klyme DM. A simple method for determining physiologically active calcium and magnesium concentrations in critically ill patients. Crit Care Med 1987;15:813-816.
  60. Zaloga GP. Bedside reagent testing: urine and GI tract specimens. J Crit Illness 1987;2:68-70,73-74,77-79.
  61. Zaloga GP. Bedside reagent testing: blood, CSF, and bacterial cultures. J Crit Illness 1988 Jan;3:85-86,88-89, 92?94.
  62. Zaloga GP, Malcolm D, Chernow B, Holaday J. Endotoxin-induced hypocalcemia results in defective calcium mobilization in rats. Circ Shock 1988;24:143-148.
  63. Zaloga GP, Prough DS. Monitoring of hepatic function. Crit Care Clin 1988;4:591-603.
  64. Prough DS, Zaloga GP. Monitoring of renal function. Crit Care Clin 1988;4:573-589.
  65. Lake CR, Chernow B, Zaloga G, Labow J, Quirk R, Hedges SM. The effects of phenylpropanolamine on human sympathetic nervous system function. Neuropsychopharmacology 1988;1:163-168.
  66. Malcolm DS, Zaloga GP, Willey SC, Amir S, Holaday JW. Naloxone potentiates epinephrine's pressor actions in endotoxemic rats. Circ Shock 1988;25:259-265.
  67. Zaloga GP. Catecholamines in anesthetic and surgical stress. Int Anesth Clin 1988;26:187-198.
  68. Lake CR, Zaloga G, Clymer R, Quirk R, Chernow B. A double dose of phenylpropanolamine causes transient hypertension. Am J Med 1988;85:339-343.
  69. Prough DS, Zaloga GP. Management of acute oliguria in the elderly patient. Int Anest Clin 1988;26:112-118.
  70. Zaloga GP, Willey S, Malcolm D, Chernow B, Holaday JW. Hypercalcemia attenuates the blood pressure response to epinephrine. J Pharmacol Exp Ther 1988;247:949-952.
  71. Reed HL, Chernow B, Lake CR, Zaloga GP, Stoiko MA, Beardsly D, Cruess D, Lee C, Smallridge RC. Alterations in sympathetic nervous system activity with intraoperative hypothermia during coronary artery bypass surgery. Chest 1989;95:616-622.
  72. Chernow B, Zaloga GP. Calcium homeostasis and calcium channels. Critical Care - State of Art 1989;10:79-100.
  73. Zaloga GP, Hill TR, Strickland RA, Kennedy D, Visser M, Ford K, Whitley J, Holt G, Booker C. Bedside blood gas and electrolyte monitoring in critically ill patients. Crit Care Med 1989;17:920-925.
  74. Strickland RA, Hill TR, Zaloga GP. Bedside analysis of arterial blood gases and electrolytes during and after cardiac surgery. J Clin Anesthesia 1989;1:248-252.
  75. Malcolm DS, Zaloga GP, Holaday JW. Calcium administration increases the mortality of endotoxic shock in rats. Crit Care Med 1989;17:900-903.
  76. Lake CR, Zaloga GP, Bray J, Rosenberg D, Chernow B. Transient hypertension after two phenylpropanolamine diet aids and the effects of caffeine: a placebo controlled follow-up study. Am J Med 1989;86:427-432.
  77. Zaloga GP. Calcium homeostasis in the critically ill patient. Magnesium 1989;8:190-200.
  78. Prielipp RC, Hill T, Washburn D, Zaloga GP. Circulating calcium modulates epinephrine-induced cyclic adenosine monophosphate production. Cardiovasc Res 1989;23:838-841.
  79. Zaloga GP, Hill T. Advances in diagnostic testing for urinary tract infections. Inf Urol 1989;2:117-125.
  80. Zaloga GP, Strickland RA, Butterworth JF, Mark LJ, Mills SA, Lake CR. Calcium attenuates epinephrine's beta-adrenergic effects in post-operative heart surgery patients. Circulation 1990;81:196-200.
  81. Zaloga GP, Hughes SS. Oliguria in patients with normal renal function. Anesthesiology 1990;72:598-602.
  82. Butterworth JF, Strickland RA, Mark LJ, Kon ND, Zaloga GP. Calcium does not augment phenylephrine's hypertensive effects. Crit Care Med 1990;18:603-606.
  83. Malcolm DS, Zaloga GP. Adjunctive pharmacotherapy in sepsis. I. Calcium, immunomodulators, opiate antagonists. Inf Surgery 1990;9:35-40.
  84. Zaloga GP. Evaluation of bedside testing options for the critical care unit. Chest 1990;97:S185-190.
  85. Malcolm DS, Zaloga GP. Adjunctive pharmacotherapy in sepsis. II. Steroids, lipid mediators, gut barrier, antacids, gut decontamination. Inf Surgery 1990;9:49-54.
  86. Meredith JW, Ditesheim JA, Zaloga GP. Visceral protein levels in trauma patients are greater with peptide diet than intact protein diet. J Trauma 1990;30:825-829.
  87. Lake CR, Rosenberg DB, Gallant S, Zaloga G, Chernow B. Phenylpropanolamine increases plasma caffeine levels. Clin Pharm Therapeutics 1990;47:675-685.
  88. Zaloga GP, MacGregor DA. What to consider when choosing enteral or parenteral nutrition. J Crit Illness 1990;5:1180-1200.
  89. Zaloga GP. Physiologic effects of peptide-based feeding. Nutrition Clinical Practice 1990;5:231-237.
  90. Zaloga GP, Knowles R, Ward K, Prielipp R. Total parenteral nutrition (TPN) increases mortality following hemorrhage. Crit Care Med 1991;19:54-59.
  91. Zaloga GP, Ward KA, Prielipp RC. The effect of enteral diets on whole body and gut growth in unstressed rats. J Parenteral Enteral Nutr 1991;15:42-47.
  92. Prielipp RC, Butterworth JF, Zaloga GP, Robertie PG, Royster RL. Effects of amrinone on cardiac index, venous oxygen saturation, and venous admixture in patients recovering from cardiac surgery. Chest 1991;99:820-825.
  93. Robertie PG, Butterworth JF, Royster RL, Prielipp RC, Dudas L, Black KW, Cole LR, Zaloga GP. Normal parathyroid hormone responses to hypocalcemia during cardiopulmonary bypass. Anesthesiology 1991;75:43-48.
  94. Zaloga GP. Monitoring versus testing technologies: present and future. MLO (Supplement) 1991;23:20-31.
  95. Prielipp RC, Zaloga GP, Butterworth JF, Robertie PG, Dudas LM, Black KW, Royster RL. Magnesium inhibits the hypertensive but not the cardiotonic actions of low dose epinephrine. Anesthesiology 1991;74:973-979.
  96. Lake CR, Rosenberg DB, Gallant S, Zaloga G, Chernow B. Dose-dependent response to phenylpropanolamine: inhibition of Orthostasis. J Clin Pharmacol 1991;31:624-635
  97. Prielipp RC, Zaloga GP. Life-threatening hypocalcemia following abdominal aortic aneurysm repair in patients with renal insufficiency. Anesth Analg 1991;73:638-641.
  98. Zaloga GP. Bedside method for placing small bowel feeding tubes in critically ill patients -A prospective study. Chest 1991;100:1643-1646.
  99. Royster RL, Butterworth JF, Prielipp RC, Robertie PG, Kon ND, Tucker WY, Dudas LM, Zaloga GP. A randomized, blinded, placebo-controlled evaluation of calcium chloride and epinephrine for emergence from cardiopulmonary bypass. Anesth Analg 1992;74:3-13.
  100. Butterworth JF, Zaloga GP, Prielipp RC, Tucker WY, Royster RL. Calcium inhibits the cardiac stimulating properties of dobutamine but not amrinone. Chest 1992;101:174-180.
  101. Zaloga GP, Ward KW, Prielipp R. The effect of rate of enteral nutrient supply on gut mass. J Parenteral Enteral Nutrition 1992;16:39-42.
  102. Zaloga GP, Bortenschlager L, Black KW, Prielipp R. Immediate post-operative enteral feeding decreases weight loss and improves wound healing following abdominal surgery in rats. Crit Care Med 1992;20:115-118.
  103. Zaloga GP. Hypocalcemia in the critically ill. Crit Care Med 1992;20:251-262.
  104. Zaloga GP. Hypophosphatemia in patients with chronic obstructive pulmonary disease. J Crit Illness 1992;7:364-375.
  105. Zaloga GP, Sager A, Black KW, Prielipp R. Low dose calcium administration increases mortality during septic peritonitis in rats. Circ Shock 1992;37:226-229.
  106. Robertie PG, Butterworth JF, Prielipp RC, Tucker WY, Zaloga GP. Parathyroid hormone responses to marked hypocalcemia in infants and young children undergoing repair of congenital heart disease. J Am Coll Cardiol 1992;20:672-677.
  107. Butterworth JF, Prielipp RC, Royster RL, Spray BJ, Kon ND, Wallenhaupt SL, Zaloga GP. Dobutamine increases heart rate more than epinephrine in patients recovering from aortocoronary bypass surgery. J Cardiothorac Vasc Anesth 1992; 6: 535-541.
  108. Zaloga GP, Washburn D, Black KW, Prielipp R. Human sepsis increases lymphocyte intracellular calcium. Crit Care Med 1993; 21: 196-202.
  109. Suleiman MY, Zaloga GP: How and when to manage hypocalcemia in critically ill patients. J Crit Illness 1993; 8: 372-390.
  110. Zaloga GP, Roberts P, Black KW, Prielipp R: Gut bacterial translocation/dissemination explains the increased mortality produced by parenteral nutrition following methotrexate. Circulatory Shock 1993; 39: 263-268
  111. Zaloga GP: Reagent Testing - Part 1: Rapid, accurate urine testing at the bedside. Consultant 1993; 33: 90-98.
  112. Zaloga GP: Reagent Testing - Part 2: Bedside testing of gastrointestinal tract specimens. Consultant 1993; 33: 80-82.
  113. Zaloga GP: Reagent Testing - Part 3: Testing Blood Specimens at Your Patient's Bedside. Consultant 1993; 33: 111-117.
  114. Zaloga GP, Dudas L, Roberts P, Bortenschlager L, Black K, Prielipp R: Near-patient blood gas and electrolyte analyses are accurate when performed by non-lab trained individuals. J Clinical Monitoring 1993; 9: 341-346.
  115. Royster RL, Butterworth JF, Prielipp RC, Zaloga GP et al: Combined inotropic effects of amrinone and epinephrine after cardiopulmonary bypass in humans. Anesth Anal 1993; 77: 662-672.
  116. Zaloga GP: Glucagon and the critically ill patient. International Glucagon Monitor 1993; 3: 8-16.
  117. Zaloga GP, Roberts P: Permissive Underfeeding. New Horizons 1994; 2: 257-263.
  118. Roberts P, Zaloga GP: Dietary Bioactive Peptides. New Horizons 1994; 2: 237-243.
  119. MacGregor DA, Butterworth JF, Zaloga GP, Prielipp RC, James R, Royster RL: Hemodynamic and renal effects of dopexamine and dobutamine in patients with reduced cardiac output following coronary artery bypass grafting. Chest 1994; 106: 835-841.
  120. Zaloga GP, Ackerman MH: A review of disease specific formulas. Clinical Issues In Critical Care Nursing 1994; 5: 421-435.
  121. Bortenschlager L, Roberts PR, Black KW, Zaloga GP: Enteral feeding minimizes liver injury during hemorrhagic shock. Shock 1994; 2: 351-354.
  122. Baskin W, Jaques PF, Kudsk KA, Zaloga GP: Removing barriers to enteral access in the ICU. J Crit Care Nutr 1994; 2: 4-13.
  123. Abernethy WB, Butterworth JF, Prielipp RC, Leith JP, Zaloga GP: Calcium entry attenuates adenylyl cyclase: A possible mechanism for calcium-induced catecholamine resistance. Chest 1995; 107: 1420-1425.
  124. Prielipp RC, Butterworth JF, Roberts PR, Black KW, Zaloga GP: Magnesium antagonizes the actions of lysophosphatidyl choline (LPC) in myocardial cells: A possible mechanism for its antiarrhythmic effects. Anesthesia Analgesia 1995; 80: 1083-1087.
  125. Ririe DG, Butterworth JF, Royster RL, MacGregor DA, Zaloga GP: Triiodothyronine increases contractility independent of beta-adrenergic receptors or stimulation of cyclic-3'5'-adenosine monophosphate. Anesthesiology 1995; 82: 1004-1012.
  126. Zaloga GP: Glucagon and the critically ill patient. International Diabetes Monitor 1995; 7: 2-8.
  127. MacGregor DA, Baker AM, Appel RG, Ober KP, Zaloga GP: Hyperosmolar coma due to lithium-induced diabetes insipidus. Lancet 1995; 346: 413-417.
  128. Zaloga GP: The role of nutrition in the outcome of critically ill patients: A historical perspective. Brazilian J Clin Nutr 1995; 10: 115-124.
  129. Zaloga GP, Roberts PR, Black K, Santamauro JT, Klase E, Suleiman M: Hand-held blood gas analyzer is accurate in the critical care setting. Crit Care Med 1996; 24: 957-962.
  130. Zaloga GP, Roberts PR, Nelson TE: Carnosine: A novel peptide regulator of intracellular calcium and contractlity in cardiac muscle. New Horizons 1996; 4: 26-35.
  131. DeLegge MH, Sax HC, Zaloga GP: An Illustrated Guide to Enteral Access. Part 2: Practical aspects of specific techniques. J Crit Care Nutr 1996; 3: 26-36.
  132. Black KW, Roberts PR, Zaloga GP: New urine collection technique for monitoring acute changes in renal function of the rat. Contemporary Topics In Laboratory Animal Medicine 1996; 35: 69-70.
  133. Zaloga GP, Roberts PR, Black KW, Lin M, Sudo GZ, Sudo RT, Nelson TE: Carnosine is a novel peptide modulator of intracellular calcium and contractility in cardiac cells. Am J Physiol 1997; 272: H462-468.
  134. Cerra FB, Benitez MR, Blackburn GL et al: Consensus statement for applied nutrition in ICU patients. Chest 1997; 111: 769-778.
  135. Roberts PR, Black KW, Zaloga GP: Enteral feeding improves outcome and protects against glycerol-induced acute renal failure in the rat. Am J Resp Crit Care Med 1997; 156: 1265-1269.
  136. Owen MD, Gurun S, Zaloga GP, Millington WR: Glycyl-L-glutamine [b-endorphin 30-31] attenuates hemorrhagic hypotension in conscious rats . Am J Physiol 1997; 273: R1598-R1606.
  137. Roberts PR, Black KW, Santamauro JT, Zaloga GP: Dietary peptides improve wound healing following surgery. Nutrition 1998; 14: 266-269.
  138. Kost GJ, Ehrmeyer SS, Chernow B, Winkelman JW, Zaloga GP, Dellinger RP, Shirey T: The laboratory-clinical interface: Point-of-care (POC) testing. Chest 1999; 115: 1140-1154.
  139. Zaloga GP, Roberts PR: Bedside placement of enteral feeding tubes in the ICU. Crit Care Med 1998; 26: 987-988.
  140. Zaloga GP: Immune-enhancing enteral diets: Where’s the beef? Crit Care Med 1998; 26: 1143-1146.
  141. Ririe DG, Butterworth JF, Hines M, Hammon JW, Zaloga GP: Effects of cardiopulmonary bypass and deep hypothermic circulatory arrest on the thyroid axis during and after repair of congenital heart defects: preservation by deep hypothermia? Anesth Analg 1998; 87: 543-548.
  142. Zaloga GP: Early enteral nutritional support improves outcome: Hypothesis or fact? Crit Care Med 1999; 27: 259-261.
  143. Roberts PR, Burney JD, Black KW, Zaloga GP: Effect of chain length on absorption of biologically active peptides from the gastrointestinal tract. Digestion 1999; 60: 332-337.
  144. Hirschberg R, Kopple J, Lipsett P, et al: Multicenter clinical trial of recombinant human insulin-like growth factor I in patients with acute renal failure. Kidney International 1999; 55: 2423-2432.
  145. Welker JA, Zaloga GP: Pine oil ingestion: A common cause of poisoning. Chest 1999; 116: 1822-1826 .
  146. Zaloga GP: Dietary Lipids: Ancestral ligands and regulators of cell signaling pathways. Crit Care Med 1999; 27: 1646-1648.
  147. Zaloga GP: Ionized hypocalcemia during sepsis”, Crit Care Med 2000; 28: 266-268.
  148. Roberts PR, Zaloga SJ, Burney JD, Zaloga GP: Wine flavonoids inhibit cholera toxin-induced intestinal secretion in rats.
    J Int Care Med 2000; 15: 48-52.
  149. Zaloga GP, Marik P: Promotility agents in the ICU. Crit Care Med 2000; 28: 2657-2659.
  150. Ririe DG, Zaloga GP: Vasodilatory actions of the dietary peptide carnosine. Nutrition 2000; 16: 168-172.
  151. Roberts PR, Zaloga GP: Cardiovascular effects of carnosine. Biochemistry (Moscow) 2000; 65: 856-861.
  152. Marik PE, Lahham EL, Zaloga GP: The management of atrial fibrillation/flutter in the ICU. Int Care Med 2000; 15: 181-190.
  153. Zaloga GP, Clark JD, Roberts PR: Inhibition of nitric oxide synthase enhances the myocardial toxicity of phenylpropanolamine. Crit Care Med 2000; 28: 3679-3683.
  154. Marik PE, Zaloga GP: Hypothermia and cytokines in septic shock. Int Care Med 2000; 26: 716-721.
  155. Zaloga GP, Teres D: The safety and efficacy of propofol containing EDTA: A randomised clinical trial programme focusing on cation and trace metal homeostasis in critically ill patients. Intensive Care Medicine 2000; 26: S398-399.
  156. Higgins TL, Murray M, Kett DH, et al: Trace element elimination during continuous sedation with propofol containing EDTA in critically ill patients. Intensive Care Med 2000; 26: S413-421.
  157. Zaloga GP, Youngs E, Teres D: Propofol containing sedatives increase secretion of parathyroid hormone. Intensive Care Medicine 2000; 26: S405-412.
  158. Barr J, Zaloga GP, Haupt M, et al: Cation metabolism during propofol sedation with and without EDTA in patients with impaired renal function. Intensive Care Medicine 2000; 26: S433-442.
  159. Herr DL, Kelly K, Hall JB et al: Safety and efficacy of propofol with EDTA when used for sedation of surgical intensive care unit patients. Intensive Care Medicine 2000; 26: S452-462.
  160. Marik PE, Lynott J, Croxton M, Palmer E, Miller LE, Zaloga GP: The effect of blind-protected specimen brush sampling on antibiotic usage in patients with suspected ventilator associated pneumonia. J Intensive Care Medicine 2001; 16: 42-46.
  161. Zaloga GP: Blind bedside placement of enteric feeding tubes. Techniques in Gastrointestinal Endoscopy 2001; 3: 9-15.
  162. Zaloga GP, Todd N, Levit P, Marik P: Propofol-induced bronchodilation in patients with status asthmaticus. Internet J Emerg Intensive Care Med 2001; 5: [http://www.icaap.org/iuicode? 89.5.1.5]
  163. Marik PE, Zaloga GP: The effect of aging on circulating levels of proinflammatory cytokines during septic shock. J Am Geriatrics Soc 2001; 49: 5-9.
  164. Marik PE, Zaloga GP: CPR in terminally ill patients? Resuscitation 2001; 49: 99-103.
  165. Zaloga GP: Sepsis-induced Adrenal Deficiency Syndrome (SIADS). Crit Care Med 2001; 29: 688-690.
  166. Marik PE, Zaloga GP: Early enteral nutrition in acutely ill patients: A systematic review Crit Care Med 2001; 29: 2264-2270.
  167. Zaloga GP: Critical Care Nurition: Present status and future perspectives. Jap J Surg Metab Nutr 2001; 35: 297-308.
  168. Marik PE, Kiminyo K, Zaloga GP: Adrenal insufficiency in critically ill patients with human immunodeficiency virus. Crit Care Med 2002; 30: 1267.
  169. Marik PE, Zaloga GP: Therapeutic sedation: Has its time come? Crit Care Med 2002: 30: 949-952.
  170. Zaloga GP: Aspiration related illnesses. JPEN 2002; 26 (supplement): S12-8.
  171. Consensus Statement. North American Summit on Aspiration. JPEN 2002; 26 (supplement): S80-85.
  172. Marik PE, Zaloga GP: Adrenal Insufficiency in the critically ill. Chest 2002; 122: 1784-1796.
  173. Marik PE, Glaes SB, Zaloga GP: Adrenal insufficiency during septic shock. Crit Care Med 2003; 31: 141-145.
  174. Zaloga GP, Marik P: Sulfite-induced propofol oxidation: A cause for radical concern. Crit Care Med (in press).
  175. Siddiqui RA, Jenski LJ, Wiesehan JD, Harvey KA, Stillwell W, Zaloga GP: Docosahexaenoic acid induces cell cycle arrest by inhibiting phosphorylation of retinoblastoma protein in Jurkat leukemic cells. Biochem J (in press).
  176. Zaloga GP, Marik PE: Diagnosis of adrenal insufficiency. Crit Care Med (in press).

Submitted Manuscripts:

  1. Albertson TE, Panacek EA, MacArthur RD et al: Multi-center evaluation of a human monoclonal antibody to enterobacteriaceae common antigen in patients with gram negative sepsis.
  2. Roberts P, Zaloga S, Burney JD, Zaloga GP: Fish protein inhibits cholera toxin-induced intestinal secretion in rats.
  3. Dixit B, Burakoff R, Zaloga GP: Gastric feeding in acute pancreatitis.
  4. Marik PE, Zaloga GP: Gastric vs Jejunal Feeding: A systematic review.
  5. Zieger MAJ, Al-hassani MH, Siddiqui RA, Zaloga GP: Temperature dependence of bovine aortic endothelial cell survival during pure hypothermia.

Manuscripts in Prepartation:

  1. Siddiqui R, Stillwell W, Zaloga GP: Omega-3 lipids inhibit cardiac pathologic hypertrophy and modulate translocation of protein kinase C.
  2. Zaloga GP, Zerouga M, Stillwell W, Siddiqui R: Omega-3 lipids inhibit the cardiac toxicity of tumor necrosis factor.
  3. Siddiqui R, ZalogaGP: Omega-3 lipids alter calcium flux in cardiac tissue through modulation of Ca-ATPase activity.

Published Abstracts:

  1. Finton CK, Chernow B, Bjorkland S, Zaloga G. Gentamicin induced hypomagnesemia. Crit Care Med 1982;10:220.
  2. Zaloga GP, Chernow B, Burman KD, Rainey TG, Lake CR. Hemodynamic and catecholamine response to TRH in patients undergoing cardiac surgery. Clin Res 1982;30:856A.
  3. Chernow B, Zaloga GP, Pock A, Zaritsky A, Wood B. Aminoglycoside induced hypomagnesemia. A prospective study. Clin Res 1982;30:863A.
  4. Chernow B, Zaloga G, Burman K, Quinn A, Rainey T, Zajtchuk R. Cardiopulmonary bypass surgery rapidly alters thyroid function. Clin Res 1983;31:257A.
  5. Chernow B, Zaloga G, Burman K, Chin R, Zajtchuk R, Rainey T, Lake CR. Diagnostic dosages of TRH raise blood pressure by a noncatecholamine mechanism. Clin Res 1983;31:257A.
  6. Zaloga G, Chernow B, Pock A, Wood W, Zaritsky A, Zucker A. Hypomagnesemia is a common complication of aminoglycoside therapy. Clin Res 1983;31:261A.
  7. Chernow B, Zaloga GP, Burman KD, Quinn T, Rainey TG, Zajtchuk R. Cardiopulmonary bypass surgery rapidly alters thyroid function. Crit Care Med 1983;11:240.
  8. Chernow B, Zaloga GP, Burman KD, Chin R, Zajtchuk R, Rainey TG, Lake CR. Diagnostic dosages of TRH raise blood pressure by a noncatecholamine mechanism. Crit Care Med 1983;11:246.
  9. Engler RJM, Gurney M, Zaloga GP, Eil C. Menstrual urticaria angioedema secondary to autoimmune IgE to FSH/LH. Clin Res 1983;31:679A.
  10. Engler RJM, Gurney M, Zaloga GP, Eil C. Cyclic urticaria (URT) angioedema (ANG) due to autoimmune IgE to endogenous hormone. Clin Res 1984;32:146A.
  11. Kurek T, Zaloga GP, Chernow B, Barton M, Rainey TG. Total serum T4 concentration correlates with severity of illness (APACHE score) in critically ill euthyroid patients. Clin Res 1984;32:251A.
  12. Zaloga GP, Chernow B, Cook D, Snyder R, O'Brian JT. The importance of measured serum ionized calcium levels in critically ill patients. Crit Care Med 1984;12:236.
  13. Zaloga GP, Chernow B, Zajtchuk R, Hall K, Hargraves R, Burman KD, Smallridge R, Lake CR. Critical illness decreases thyrotropin responsiveness to thyrotropin-releasing hormone - a potential cause of misinterpretation of thyroid function tests in critically ill patients. Crit Care Med 1984;12:235.
  14. Smallridge RC, Chernow B, Snyder R, Zaloga GP, Verma PS, Burman KD. Angiotensin-converting enzyme activity and thyroid function decreases acutely in critical illness. Clin Res 1984;32:253A.
  15. Zaloga GP, Anderson DM, Chernow B. Lack of correlation between degree of glucose control and thyroid hormone levels in diabetic subjects. Clin Res 1984;32:691A.
  16. Zaloga GP, Clapper M, Chernow B. Variability in the percentage of protein binding of calcium may explain the poor correlation between serum total and ionized calcium measurements in critically ill patients. Clin Res 1984;32:705A.
  17. Zaloga GP, Chernow B. Free fatty acids increase calcium binding to albumin in serum from critically ill patients. Clin Res 1985;33:296A.
  18. Zaloga GP, Malcolm D, Chernow B, Holaday J. Glucagon antagonizes morphine induced bradycardia at a site within the central nervous system. Clin Res 1985;33:290A.
  19. Zaloga GP, Malcolm D, Holaday J, Chernow B. Glucagon is a unique cardiovascular agent with anti-opiate activity. Crit Care Med 1985;13:272.
  20. Zaloga GP, Malcolm D, Holaday J, Chernow B. Glucagon reverses the hypotension and bradycardia of verapamil overdose in rats. Crit Care Med 1985;13:273.
  21. Zaloga GP, Malcolm D, Holaday J, Chernow B. Effective treatment of acute calcium cardiotoxicity with verapamil in rats. Crit Care Med 1985;13:283.
  22. Teich S, Malcolm D, Zaloga G, Holaday J, Chernow B. Beneficial effects of glucagon in endotoxic shock in rats. Circ Shock 1985;16:95.
  23. Chernow B, Zaloga GP, Malcolm D, Willey S, Holaday JW. Glucagon's chronotropic action is calcium dependent. Clin Res 1986;34:410A.
  24. Zaloga GP, Chernow B. Pathogenic mechanisms for hypocalcemia during gram negative sepsis. Crit Care Med 1986;14:405.
  25. Zaloga GP, Willey S, Chernow B. Altered calcium binding in severe illness: a common cause for misinterpretation of serum calcium values in critically ill patients. Crit Care Med 1986;14:406.
  26. Malcolm D, Zaloga G, Chernow B, Holaday J. Calcium involvement in endotoxic shock: verapamil improves hemodynamics and survival in rats. Circ Shock 1986;18:346.
  27. Willey SC, Zaloga GP, Malcolm D, Chernow B, Holaday J. Calcium inhibits epinephrine's hypertensive effect and increases mortality in endotoxemic rats. Clin Res 1986;34:868A.
  28. Zaloga GP, Malcolm D, Willey SC, Amir S, Chernow B, Holaday J. Naloxone potentiates epinephrine's hypertensive effects in endotoxemic rats. Clin Res 1986;34:868A.
  29. Zaloga GP. In-vivo and ex-vivo monitoring of the critically ill patient. Clin Chem 1987;33:865-866.
  30. Zaloga GP, Malcolm D, Holaday J. Endotoxin-induced hypocalcemia results in defective calcium mobilization in rats. Crit Care Med 1987;15:373.
  31. English JF, Coyle JP, Rainey TG, Wilkens L, Carrio J, McCormick C, Zaloga GP. Bedside laboratory testing accurately reflects main hospital laboratory results in critically ill patients. Crit Care Med 1987;15:379.
  32. Zaloga GP, Malcolm D, Willey S, Holaday J. Hypocalcemia potentiates epinephrine-stimulated hepatic gluconeogenesis in normal and endotoxemic rats. Crit Care Med 1987;15:387.
  33. Zaloga GP. Calcium homeostasis during critical illness. Magnesium 1987;6:258.
  34. Zaloga GP, Washburn D. Multiorgan failure is associated with elevated free intracellular calcium in human sepsis. Chest 1988;94(suppl):6S.
  35. Zaloga GP. Bedside placement of feeding tubes into the duodenum in critically ill patients. Chest 1988;94(suppl):50S.
  36. Strickland RA, Hill TR, Zaloga GP. Rapid bedside analysis of arterial blood gases and electrolytes improves patient care during and after cardiac surgery. Anesthesiology 1988;69:A257.
  37. Strickland RA, Mark LJ, Butterworth JF, Zaloga GP. Calcium administration attenuates the hypertensive response to phenylephrine in humans following open heart surgery. Anesthesiology 1988;69:A189.
  38. Zaloga GP, Hughes SS. Urine sodium excretion separates hypovolemic from normovolemic (hormonal excess) oliguria. Anesthesiology 1988;69:A218.
  39. Strickland RA, Mark LJ, Butterworth JF, Zaloga GP. Intravenous calcium fails to augment cardiac output following cardiac surgery. Anesthesiology 1988;69:A848.
  40. Prielipp RC, Washburn D, Zaloga GP. Albumin: an endogenous calcium antagonist? Anesthesiology 1988;69:A450.
  41. Mark LJ, Strickland RA, Butterworth JF, Washburn D, Mills SA, Kon ND, Zaloga GP. Calcium blunts epinephrine's cardiac, peripheral vascular, and hyperglycemic effects in post-operative heart surgery patients. Anesth Analg 1989;68:S181.
  42. Zaloga GP, Vilems B, Prielipp R. Acute acidosis and alkalosis augments the cyclic AMP response to epinephrine in isolated myocardial cells. Crit Care Med 1989;17:S12.
  43. Zaloga GP, Prielipp R, Hill T. Calcium (Ca) causes catecholamine resistance by altering cyclic AMP production. Crit Care Med 1989;17:S17.
  44. Meredith JW, Ditesheim JA, Zaloga GP. Visceral protein synthesis is greater with peptide-diet versus intact-protein diet in trauma patients. J Trauma 1989;29:1033.
  45. Zaloga GP, Prielipp R, Ward K. Intracellular calcium elevations cause catecholamine resistance by uncoupling beta-receptors. Chest 1989;96:123S.
  46. Zaloga GP, Prielipp R, Ward K. Plasma from patients with multiple-organ failure augments cellular calcium influx. Chest 1989;96:123S.
  47. Prielipp RC, Ward KA, Zaloga GP. Peptide-based enteral nutrition prevents liver injury during severe hemorrhagic shock in rats. Anesthesiology 1989;71:A164.
  48. Vilims BD, Prielipp RC, Ward KA, Zaloga GP. Acidosis and alkalosis fail to suppress epinephrine-induced cAMP production in rat myocardial cells. Anesthesiology 1989;71:A167.
  49. Prielipp RC, Ward KA, Zaloga GP. An endogenous lipid, lysophosphatidyl choline, increases free cytosolic calcium levels in isolated rat myocardial cells. Anesthesiology 1989;71:A472.
  50. Prielipp RC, Ward KA, Zaloga GP. Magnesium inhibits the calcium ionophoric properties of lysophosphatidyl choline, an endogenous arrhythmogenic substance. Anesthesiology 1989;71:A1154.
  51. Prielipp RC, Ward KA, Zaloga GP. Increased cytosolic calcium inhibits cAMP response to epinephrine in isolated rat myocardial cells. Anesthesiology 1989;71:A471.
  52. Robertie PG, Butterworth JF, Royster RL, Tucker WY, Zaloga GP. Transient hypoparathyroidism during CPB: calcium, magnesium, PTH, and Vitamin D homeostasis. Anesthesiology 1989;71:A81.
  53. Royster RL, Robertie PG, Butterworth JF, Kon ND, Zaloga GP. A randomized, blinded evaluation of calcium chloride, epinephrine and placebo for emergence from CPB. Anesthesiology 1989;71:A1161.
  54. Rogers AT, Zaloga GP, Prough DS, Butterworth JF IV, Robertie P, Ward KA. Hyperglycemia during cardiac surgery: central vs. peripheral mechanisms. Anesth Analg 1990;70:S328.
  55. Butterworth JF, Royster RL, Robertie PG, Zaloga GP, Prielipp RC, Dudas LM. Hemodynamic effects of amrinone in patients recovering from aortocoronary bypass surgery. Anesth Analg 1990;70:S45.
  56. Zaloga GP, Sager A, Prielipp R, Ward K. Low dose calcium administration increases mortality during septic peritonitis. Crit Care Med 1990;18:S250.
  57. Zaloga GP, Knowles R, Prielipp R, Ward K. Total parenteral nutrition (TPN) increases mortality following hemorrhage. Crit Care Med 1990;18:S209.
  58. Zaloga GP, Prielipp RC, Ward KA. Total parenteral nutrition (TPN) increases mortality following methothrexate-induced endogenous sepsis. Anesthesiology 1990;73:A1232.
  59. Zaloga GP, Prielipp RC, Ward KA. The rate of enteral feeding is important for gut maintenance. Anesthesiology 1990;73:A283.
  60. Butterworth JF, Prielipp RC, Zaloga GP, Royster RL, Robertie PG. Is dobutamine less chronotropic than epinephrine after coronary artery surgery? Anesthesiology 1990;73:A61.
  61. Prielipp RC, Butterworth JF, Zaloga GP, Robertie PG, Royster RL. Amrinone increases venous admixture and decreases arterial oxygenation (PaO2) after coronary artery bypass graft surgery (CABG). Anesthesiology 1990;73:A1230.
  62. Prielipp RC, Zaloga GP, Butterworth JF, Robertie PG, Royster RL. Magnesium inhibits the alpha-1 but not the beta-1 adrenergic actions of epinephrine in postoperative coronary artery bypass graft (CABG) patients. Anesthesiology 1990;73:A282.
  63. Robertie PG, Butterworth JF, Dudas L, Ward K, Zaloga GP. Impaired calcium mobilization in children undergoing cardiopulmonary bypass. Anesthesiology 1990;73:A1137.
  64. Zaloga GP, Sager A, Prielipp R, Ward K. Calcium administration decreases survival and exacerbates endotoxemia during peritonitis. Chest 1990;98:1355.
  65. Zaloga GP, Ward K, Prielipp R. Peptide-based enteral diets stimulate body growth and IGF-1 production. Chest 1990;98:1025.
  66. MacGregor DA, Scuderi PE, Bowton DL, Zaloga GP, Harris LE. A side-by-side comparison of four blood gas analyzers using tonometered human blood. Chest 1990;98:335.
  67. Zaloga GP, Prielipp RC, Black KW. Bacterial translocation does not explain the increased mortality produced by parenteral nutrition (TPN) following methotrexate. J Parenteral Enteral Nutr 1991;15(suppl):37.
  68. Zaloga GP, Prielipp R, Dudas L, Royster R, Butterworth J. Calcium impairs dobutamine's cardiovascular actions. Crit Care Med 1991;19(suppl):S52.
  69. Bortenschlager L, Zaloga GP, Ward-Black K, Prielipp R. Immediate post-operative enteral feeding improves wound healing following abdominal surgery in rats. Crit Care Med 1991;19(suppl):S56.
  70. Wilson HA, Chin R, Adair NE, Zaloga GP. Phenylpropanolamine significantly reduces the clearance of theophylline. Am Rev Resp Dis 1991;143(suppl):A629.
  71. Zaloga GP. Calcium antagonists improve survival during experimental sepsis: A meta-analysis. Chest 1991;100:83S.
  72. Zaloga GP, Black KW, Prielipp R. Enteral feeding minimizes liver damage following hemorrhage. Chest 1991;100:135S.
  73. Zaloga GP, Dudas L, Bortenschlager L, Roberts P, Black K, Prielipp R. Near-patient blood gas and electrolyte analyses are accurate when performed by non-lab trained individuals. Chest 1991;100:121S.
  74. Prielipp R, Zaloga GP, Dudas L, Black K. Bedside blood gas and electrolyte monitoring in critically ill patients. Anesthesiology 1991;75:A485.
  75. Zaloga GP, Bortenschlager L, Black K. Early postoperative administration of enteral or parenteral nutrients improves wound healing. J Parenteral Enteral Nutr 1992;16(suppl):28S.
  76. Bortenschlager L, Black K, Zaloga G. Human sepsis impairs lymphocyte slow calcium channel function. Crit Care Med 1992;20:S49.
  77. Zaloga G, Meredith JW, Roberts P, Bortenschlager L, Black K, Henningfield M. Improved hepatic protein responses with hydrolyzed protein versus intact protein diets after trauma. Crit Care Med 1992;20:S94.
  78. Zaloga G, Roberts P, Black K, Prielipp R, Royster R, Butterworth J. The hemodynamic effects of calcium and dobutamine are additive in patients with sepsis. Anesthesiology 1992;77:A223.
  79. Butterworth JF, Prielipp RC, Royster R, James R, Zaloga GP. A randomized, blinded comparison of dopexamine with dobutamine in patients with reduced cardiac output after coronary artery surgery. Anesthesiology 1992;77:A54.
  80. Prielipp RC, Butterworth J, Pang J, Zaloga GP. Does calcium inhibit catecholamine action at B2 receptors by interfering with production of cyclic adenosine monophosphate? Anesthesiology 1992;77:A233.
  81. Roberts P, Black K, Zaloga GP: Peptide-based enteral diets improve wound healing after abdominal surgery in rats. J Parenteral Enteral Nutr 1993; 17: 32S.
  82. Roberts P, Meredith JW, Black K, Zaloga GP: Diarrhea does not alter impaired small bowel absorption following trauma. J Parenteral Enteral Nutr 1993; 17: 34S.
  83. Roberts P, Black K, Zaloga G: Enteral nutrition improves survival and prevents bacterial dissemination following methotrexate. Crit Care Med 1993; 21: S287.
  84. Roberts P, Suleiman M, Black K, Zaloga G: Protein hydrolysates inhibit cyclic AMP generation: A mechanism for inhibition of secretory diarrhea. Crit Care Med 1993; 21: S184.
  85. Roberts P, Bortenschlager L, Black K, Zaloga G: Early enteral feeding minimizes liver injury following hemorrhage but not endotoxemia. Chest 1993; 104 (suppl): 58S.
  86. Roberts P, Black K, Zaloga G: Histidine infusion enhances free water clearance. Chest 1993; 104 (suppl): 2S.
  87. Zaloga GP, Abernethy WB, Butterworth JF: Calcium entry inhibits adenylyl cyclase activity: A mechanism for resistance to Beta-adrenergic agonists. Anesthesiology 1993; 79: A281.
  88. Roberts P, Zaloga G, Black K: Histidine infusion enhances free water excretion by inhibiting cAMP generation in the kidney. Anesthesiology 1993; 79: A278.
  89. Zaloga G, Santamauro J, Roberts P, Klase E, Black K: Hand-held blood gas analyzer is accurate in the critical care setting. Crit Care Med 1994; 22: A26.
  90. Roberts P, Black K, Zaloga G: Early enteral feeding improves survival and decreases renal injury from rhabdomyolysis. Crit Care Med 1994; 22: A76.
  91. Roberts P, Black K, Zaloga G: Histidine enhances free water clearance and decreases urinary cAMP excretion. Crit Care Med 1994; 22: A210.
  92. Zaloga GP: Requirements of sensor performance for near-patient testing. Clin Chemistry 1994; 40: 1174.
  93. Ririe DG, Butterworth JF, Hines H, Hammon JW, Zaloga GP: Effects of cardiopulmonary bypass and deep hypothermic circulatory arrest on thyroid function during repair of congenital heart defects. Anesthesiology 1994; 81: A1391.
  94. Roberts P, Black K, Zaloga GP: Small bowel absorption of bioactive peptides in rats: Implications for nutritional support. Crit Care Med 1995; 23(S): A98.
  95. Roberts P, Suleiman K, Meredith JW, Zaloga GP: Early enteral nutrition is well tolerated in critically ill trauma patients: Advantages of small bowel feeding with concentrated formulas. Crit Care Med 1995; 23(S): A100.
  96. Zaloga G, Suleiman K, Roberts P, Jain A, Meredith JW: Protein intake modulates glomerular filtration rate in trauma patients. Crit Care Med 1995; 23(S): A104.
  97. Panacek EA, MacArthur RD, Johnson SB, Albertson TE, Maki D, Tobias J, Benjamin E, Zaloga G, Matuschak G, Silverstein J, Black G, for the T88 Sepsis Study Group. Results of a phase III Clinical Trial of the human monoclonal antibody MAB-T88 versus placebo in gram negative sepsis. Crit Care Med 1995; 23(S): A170.
  98. Roberts PR, Black KW, Matheis E, Zaloga GP: Fiber based diet decreases bacterial adherence in the colon of rats. Am J Resp Crit Care Med 1995; 151: A243.
  99. Roberts PR, Black KW, Zaloga GP: Inotropic properties of the dietary peptide carnosine. Am J Resp Crit Care Med 1995; 151: A706.
  100. Zaloga GP: Nutrition in the immunocompromised patient. J Am Coll Nutr 1995; 14: 528-529.
  101. Roberts PR, Black KW, Zaloga GP: Acidosis does not impair cardiac function in the isolated heart. Anesthesiology 1995; 83: A255.
  102. Zaloga SJ, Black KW, Roberts PR, Zaloga GP: Dietary peptide profile modulates body nitrogen utilization: implications for nutritional support. Anesthesiology 1995; 83:A242.
  103. Roberts PR, Black KW, Zaloga GP: Early enteral feeding improves survival and renal function following muscle injury. Anesthesiology 1995; 83: A241.
  104. Owen MD, Millington WR, Zaloga GP: Glycyl-l-glutamine, a beta-endorphin-derived peptide, restores blood pressure following acute hemorrhage in rats. Anesthesiology 1995; 83: A541.
  105. Roberts PR, Zaloga GP, Black KW: Inotropic actions of the dietary peptide carnosine are not mediated via the beta-adrenergic receptor. Crit Care Med 1996; 24: A30.
  106. Roberts PR, Zaloga GP, Black KW: Gastrointestinal absorption of bioactive proteins: Implications for dietary modulation of organ function. Crit Care Med 1996; 24: A40.
  107. Roberts PR, Black KW, Zaloga GP: Enteral carnosine supplementation improves wound healing in rats after surgery. Crit Care Med 1996; 24: A111.
  108. Roberts PR, Zaloga GP, Black KW: Carnosine’s inotropic actions are mediated via changes in intracellular calcium. Anesthesiology 1996; 85: A548.
  109. Zaloga GP, Roberts PR, Black KW: Nitric oxide inhibition exacerbates the myocardial depressant effects of phenylpropanolamine (PPA). Anesthesiology 1996; 85: A295.
  110. Roberts PR, Zaloga GP et al: Decreased cardiac carnosine levels may contribute to myocardial dysfunction in sepsis. Anesthesiology 1996; 85: A217.
  111. Ririe D, Zaloga GP et al: The dietary dipeptide carnosine causes vascular relaxation, but not its constituent amino acids beta-alanine and l-histidine. Anesthesiology 1996; 85: A603.
  112. Zaloga SJ, Roberts PR, Black KW, Burney JD, Zaloga GP: Antibacterial properties of wine: Potential role for nutritional support. Crit Care Med 1997; 25 (supplement): A79.
  113. Zaloga GP, Roberts PR: The dietary peptide carnosine improves myocardial contractility following endotoxin administration.
    Proceedings from the 7th World Congress of Intensive and Critical Care Medicine, Ottawa, Canada, July 1997.
  114. Roberts PR, Zaloga GP: Dietary nutrients block bacterial adherence to colonic mucosa. Proceedings from the 7th World Congress of Intensive and Critical Care Medicine, Ottawa, Canada, July 1997.
  115. Roberts PR, Black KW, Zaloga GP: Effect of fasting and refeeding on renal blood flow: Implications for perioperative management. Anesthesiology 1997; 87: A228.
  116. Roberts PR, Black KW, Zaloga GP: Short-term continuous enteral feeding improves renal blood flow. Crit Care Med 1998; 26 (suppl): A89.
  117. Roberts PR, Zaloga GP: Wine inhibits enterotoxin-induced secretory diarrhea. Crit Care Med 1998; 26 (suppl): A90.
  118. Zaloga SJ, Roberts PR, Burney JD, Black KW, Zaloga GP: Immune-enhancing formulas produce different anabolic effects. Crit Care Med 1998; 26 (suppl): A89.
  119. Roberts PR, Black KW, Zaloga GP: Enteral nutrition blunts decrease in mesenteric blood flow during high dose phenylephrine administration. Crit Care Med 1999; 27 (suppl): A77.
  120. Marik PE, Lynott J, Croxton M, Palmer E, Miller LE, Zaloga GP: The effect of blind-protected specimen brush (B-PSB) sampling on antibiotic usage in patients with suspected ventilator associated pneumonia (VAP). Crit Care Med 1999; 27: A117.
  121. Todd N, Marik PE, Zaloga GP: Bolus versus continuous gastric nutrient administration: efficacy and risk for pneumonia in critically ill patients. Crit Care Med 1999; 27: A119.
  122. Higgins TL, Murray MJ, Kett DH et al: Trace metal elimination during continuous sedation with propofol containing EDTA in critically ill patients. Crit Care Med 1999; 27: A131.
  123. Marik PE, Zaloga GP: Hypothermia and cytokines in septic shock. Crit Care Med 1999; 27: A136.
  124. Marik PE, Kiminyo K, Olexo S, Zaloga GP: Occult adrenal insufficiency in critically ill patients: an underdiagnosed entity. Crit Care Med 1999; 27: A141.
  125. Zaloga GP, Teres D: Critical Illness is associated with elevated parathyroid hormone. J Critical Care 2000
  126. Zaloga GP, Teres D, Youngs E: Short-term propofol sedation increases serum levels of parathyroid hormone independent of calcium levels in normal subjects. J Critical Care 2000
  127. Marik P, Rotello L, Zaloga GP: Secondary adrenal insufficiency is common in critically ill patients. Crit Care Med 2001; 29: A163.
  128. Zaloga GP, Siddiqui R, Hunter M, Stillwell W: Omega-3 long chain fatty acids inhibit pathologic hypertrophy of cardiomyocytes by modulating activation of protein kinase C. Chest 2002; 122 (supplement): 14S.

Miscellaneous:

  1. Zaloga GP, Chernow B. Anaphylactic reaction to tetanus toxoid: the reply. Ann Allergy 1982;49:308. (Letter)
  2. Zaloga GP, Chernow B. Postprandial hypoglycemia after antireflux surgery. Gastroenterology 1983;85:1230. (Letter)
  3. Zaloga GP. 1984 yearbook of critical care medicine. Rogers MC, ed. Chicago: Year Book Medical Publishers, 1984. Milit Med 1985;150:A24. (Book Review)
  4. Chernow B, Zaloga GP. Metabolic and endocrine emergencies: recognition and management. Bacchus H, ed. Baltimore: University Park Press, 1984. Crit Care Med 1985;13:140. (Book Review)
  5. Zaloga GP, Chernow B. Hypocalcemia and rhabdomyolysis: In reply. JAMA 1987;257:626. (Letter)
  6. Zaloga GP. Interpretation of the serum magnesium level. Chest 1989;95:257. (Editorial)
  7. Hughes SS, Zaloga GP. Scopolamine anisocoria. Ann Emerg Med 1989;18:423-424. (Letter)
  8. Zaloga GP. Endocrine function after brain death. Crit Care Med 1990;18:785-786. (Editorial)
  9. Zaloga GP. Bedside blood gas and electrolyte monitoring in critically ill patients. Crit Care Med 1990;18:684-685. (Letter)
  10. Zaloga GP. Oliguria. In reply. Anesthesiology 1990;73:584-585. (Letter)
  11. Eisenach J, Zaloga GP. Magnesium, anesthesia, and hemodynamic control. Anesthesiology 1991;74:1-2. (Editorial)
  12. Zaloga GP. After septic insult, give nutrition enterally - the sooner the better. J Crit Illness 1991;6:848-849. (Editorial)
  13. Butterworth JF, Royster RL, Prielipp RC, Zaloga GP. Should calcium be administered prior to separation from cardiopulmonary bypass? In reply. Anesthesiology 1991;75:1121-1122.
  14. Zaloga GP. Metabolic alterations in the critically ill patient. Crit Care Med 1992;20:9. (Editorial)
  15. Scheidegger D, Singer M, Zaloga GP, Bellomo R, Hawker F, Shelly P, Goris RJA: Grand rounds in intensive care. Clin Intensive Care 1993; 4: 196-202 (case discussion).
  16. Zaloga GP: Human sepsis and lymphocyte intracellular calcium. In reply. Crit Care Med 1994; 22: 178.
  17. Zaloga GP: Frontiers in Critical Care Nutrition. New Horizons 1994; 2: 121 (preface).
  18. Zaloga GP: Beware of errors in blood glucose measurement. Crit Care Med 1997; 25 (editorial): 212.
  19. Zaloga GP: Prologue to Nutrition in the Critically Ill Patient, Gris JR (ed), McGraw-Hill, Mexico, 1996.
  20. Invited commentary on “A prospective, randomized, double-blind, controlled clinical trial of enteral immunonutrition in the critically ill. Crit Care Med 1998; 26: 1164-1172", Journal Club of Assembly on Critical Care of American Thoracic Society, September 1998, www.thoracic.org.
  21. Invited commentary on “Compared with parenteral nutrition, enteral feeding attenuates the acute phase response and improves disease severity in acute pancreatitis. Gut 1998; 42: 431-435", Journal Club of Assembly on Critical Care of American Thoracic Society, October 1998, www.thoracic.org.
  22. Invited commentray on “Randomised trial of glutamine-enriched enteral nutrition on infectious morbidity in patients with multiple trauma. Lancet 1998; 352: 772-776", Journal Club of Assembly on Critical Care of American Thoracic Society, November 1998, www.thoracic.org.
  23. Invited commentary on “Non-protein energy overloading induces bacterial translocation during total parenteral nutrition in newborn rabbits. Nutrition 1998; 14: 443-447", Journal Club of Assembly on Critical Care of American Thoracic Society, December 1998, www.thoracic.org.
  24. Invited commentary on “Growth hormone inhibits apoptosis and up-regulates reactive oxygen intermediates production by human neutrophils. J Par Ent Nutr 1998; 22: 368-374", Journal Club of Assembly on Critical Care of American Thoracic Society, January 1999, www.thoracic.org.
  25. Zaloga GP, Marik P: Immune Enhancing Diets. Crit Care Med 2000; 28 (Letter): 904-906.
  26. Invited commentary on “Leptin prevents respiratory depression in obesity. Am J Respir Crit Care Med 1999; 159: 1477-1484", Journal Club of Assembly on Critical Care of American Thoracic Society, May 1999, www.thoracic.org.
  27. Invited commentary on “Docosahexaenoic acid and smoking-related chronic obstructive pulmonary disease. Am J respir Crit care Med 1999; 159: 1780-1785", Journal Club of Assembly on Critical Care of American Thoracic Society, June 1999, www.thoracic.org.
  28. Invited commentary on “Effect of nasogastric tube size on gastroesophageal reflux and microaspiration in intubated patients. Ann Intern Med 1999; 130: 991-994", Journal Club of Assembly on Critical Care of American Thoracic Society, July 1999, www.thoracic.org.
  29. Invited commentary on “Enteral tube feeding in the intensive care unit: Factors impeding adequate delivery. Crit care Med 1999; 27: 1252-1256", Journal Club of Assembly on Critical Care of American Thoracic Society, August 1999, www.thoracic.org.
  30. Invited commentary on “Selenium replacement in patients with severe systemic inflammatory response syndrome improves outcome? Crit Care Med 1999; 27: 1807-1813", Journal Club of Assembly on Critical Care of American Thoracic Society, October 1999, www.thoracic.org.
  31. Invited Commentary on “Prospective randomized controlled trial to determine the effect of early enhanced enteral nutrition on outcome in mechanically ventilated patients suffering head injury. Crit care Med 1999; 27: 2525-2531", Journal Club of Assembly on Critical Care of American Thoracic Society, November 1999, www.thoracic.org.
  32. Invited Commentary on “Increased mortality associated with growth hormone treatment in critically ill adults. N Engl J Med 1999; 341: 785-792.” Journal Club of Assembly on Critical Care of American Thoracic Society, December 1999, www.thoracic.org.
  33. Invited Commentary on “Immunonutrition in the critically ill: A systematic review of clinical outcome Crit Care Med 1999; 27: 2799-2805.” Journal Club of Assembly on Critical Care of American Thoracic Society, January 2000, www.thoracic.org.
  34. Invited Commentary on “Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: Results of the GISSI-Prevenzione trial. Lancet 1999; 354: 447-455.” Journal Club of Assembly on Critical Care of American Thoracic Society, February 2000, www.thoracic.org.
  35. Invited Commentary on “An Immune-enhancing enteral diet reduces mortality rate and episodes of bacteremia in septic intensive care unit patients. Crit Care Med 2000; 28: 643-648.” Journal Club of Assembly on Critical Care of American Thoracic Society, March 2000, www.thoracic.org.
  36. Invited commentary on “Potentiation of vitamin K antagonists by high-dose intravenous methylprednisolone. Ann Intern Med 2000; 132: 631-635.” Journal Club of Assembly on Critical Care of American Thoracic Society, April 2000, www.thoracic.org.
  37. Invited commentary on “Effects of propofol on hemodynamic and inflammatory responses to endotoxemia in rats. Crit Care Med 2000; 28: 1101-1106.” Journal Club of Assembly on Critical Care of American Thoracic Society, May 2000, www.thoracic.org.
  38. Invited commentary on “The incidence of ventilator-associated pneumonia and success in nutrient delivery with gastric versus small intestinal feeding: a randomized clinical trial. Crit Care Med 2000; 28: 1742-1746.” Journal Club of Assembly on Critical Care of American Thoracic Society, June 2000, www.thoracic.org.
  39. Marik PE, Zaloga GP: Prognostic Value of Cortisol response in Septic Shock. JAMA 2000; 284: 308-309.
  40. Invited commentary on “Intestinal absorption in patients after cardiac surgery. Crit Care Med 2000; 28: 2217-2223". Journal Club of Assembly on Critical Care of American Thoracic Society, July 2000, www.thoracic.org.
  41. Invited commentary on “Effect of intravenous omega-3 and omega-6 lipid emulsions on equine monocyte fatty acid composition and inflammatory mediator production in vitro. Shock 2000; 14: 222-228". Journal Club of Assembly on Critical Care of American Thoracic Society, August 2000, www.thoracic.org.
  42. Invited commentary on “Plasma cortisol is often decreased in patients treated in an intensive care unit. Intensive Care Med 2000; 26: 545-551". Journal Club of Assembly on Critical Care of American Thoracic Society, October 2000, www.thoracic.org.
  43. Zaloga GP, Marik PE: All propofol’s are not created equal. Crit Care Med Crit care Med 2001; 29: 465.
  44. Marik P, Zaloga GP: The CNS-hypothalamic-pituitary-adrenal axis in sepsis. Crit Care Med (letter) 2002; 30: 490-491.